Гормонотерапия в акушерстве и гинекологии. Иллюзии и реальность

Список литературы

Aarskog D. Maternal progestins as a possible cause of hypospadias. N. Engl. J. Med., 1979; 300:75–78.

Aboulghar M. A., et al. Prospective randomized study comparing luteal phase support for ICSI patients up to the first ultrasound compared with an additional three weeks. Hum. Reprod., 2008; 23:857–862.

Abplanalp J. M., et al. Cortisol and growth hormone responses to psychological stress during the menstrual cycle. Psychosom. Med., 1977; 39:158–177.

Abuzeid M. I., Sasy M. A. Elevated progesterone levels in the late follicular phase do not predict success of in vitro fertilization-embryo transfer. Fertil. Steril. 1996; 65:981–985.

ACOG Committee on Gynecologic Practice. ACOG Committee Opinion #322: Compounded bioidentical hormones. Obstet. Gynecol., 2005; 106 (5, pt1):1139–1140.

Adlercreutz H., Martin F. Biliary excretion and intestinal metabolism of progesterone and estrogens in man. J. Steroid. Biochem., 1980; 13:231–244.

Aghajanova L., Velarde M. C., Giudice L. C. Altered gene expression profiling in endometrium: evidence for progesterone resistance. Seminars in Reproductive Medicine 2010; 28:51–58.

Aghajanova L., Velarde M. C., Giudice L. C. The progesterone receptor coactivator Hic-5 is involved in the pathophysiology of endometriosis. Endocrinol., 2009; 150:3863–3870.

Alam V., Vega M., Risquez F. Luteal phase support. Reprod. Biomed. Online, 2001; 3:250–262.

Al-Asmakh M. Reproductive functions of progesterone. East Fertility Society Journal, 2007; 12 (3):147–152.

Albrektsen G., et al. Breast cancer risk by age at birth, time since birth and time intervals between births: exploring interaction effects. Br. J. Cancer., 2005; 92:161–175.

Albrektsen G., et al. Clinical stage of breast cancer by parity, age at birth, and time since birth: a progressive effect of pregnancy hormones? Cancer Epidemiol. Biomarkers Prev., 2006;15:65–69.

Albrektsen G., et al. Pregnancy Levels of Estrogen and Progesterone: The Double-Edged Sword. Cancer Epidemiol. Biomarkers Prev., 2007; 16:634–635.

Allen E., Doisy E. A.: An ovarian hormone: Preliminary report on its localization, extraction and action in test animals. JAMA, 1923; 81:819–821.

Allen W. M. Recollections of My Life with Progesterone. Gynecol. Invest., 1974; 5:142–182.

Allen W. M. The isolation of crystalline progestin. Science, 1935; 82 (2118):89–93.

Allred K. F., et al. Trigonelline Is a Novel Phytoestrogen in Coffee Beans. J. Nutr., 2009; 139:1833–1838.

Al-Sabbagh M., Lam E., Brosens J. J. Mechanisms of endometrial progesterone resistance. Mol. Cel. Endocrinol., 2012; 358: 208–215.

Ambhaikar M., Pur C. Cell surface binding sites for progesterone on human spermatozoa. Mol. Hum. Reprod., 1998; 4:413–421.

American College of Obstetricians and Gynecologist. Use of progesterone to reduce preterm birth: ACOG committee opinion, No. 2919. Obstet Gynecol, 2003; 102:1115–1116.

American College of Obstetricians and Gynecologist. Use of progesterone to reduce preterm birth: ACOG committee opinion, No. 419. Obstet. Gynecol., 2008; 112:963.

American College of Obstetricians and Gynecologists (ACOG). ACOG practice bulletin. Management of recurrent early pregnancy loss. Int. J. Gynecol. Obstet., 2002; 78:179–190.

American College of Obstetricians and Gynecologists (ACOG). Early pregnancy loss. ACOG technical bulletin. No. 212. Washington DC: American College of Obstetricians and Gynecologists, 1995.

American College of Obstetricians and Gynecologists. Compounded bioidentical hormones. ACOG Committee Opinion. No. 322. Obstet. Gynecol., 2005; 106 (1):1139–1140.

American College of Obstetricians and Gynecologists. Premenstrual Syndrome. ACOG Practice Bulletin. No. 15. Washington, DC: American College of Obstetricians and Gynecologists, 2000.

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed., Text Revision. Washington, DC: American Psychiatric Association, 2000.

Andersen A. N., et al. Progesterone supplementation during early gestations after IVF or ICSI has no effect on the delivery rates: a randomized controlled trial. Hum Reprod, 2002; 17:357–361.

Andréen L., et al. Pharmacokinetics of progesterone and its metabolites allopregnanolone and pregnanolone after oral administration of low-dose progesterone. Maturitas, 2006; 54:238–244.

Angst J., et al. The epidemiology of premenstrual psychological symptoms. Acta Psychiatr. Scand., 2001; 104:110–116.

Anserini P., et al. Luteal phase support in assisted reproductive cycles using either vaginal (Crinone 8) or intramuscular (Prontogest) progesterone: results of a prospective randomized study. Minerva Ginecol., 2001; 53:297–301.

Antonipillai J., et al. The origin of plasma deoxycorticosterone in men and in women during the menstrual cycle. J. Clin. Endocrinol. Metab., 1983; 56:93–98.

Aoki K., et al. Preconceptional natural killer cell activity as a predictor of miscarriage. Lancet, 1995; 345:1340–1342.

Apter D., Vihko R. Early menarche, a risk factor for breast cancer, indicates early onset of ovulatory cycles. J. Clin. Endocrinol. Metab.,1983; 57:82–86.

Apter D. Serum steroids and pituitary hormones in female puberty: a partly longitudinal study. Clin. Endocrinol. (Oxf), 1980; 12:107–120.

Archer D. F., et al. Initial and steady-state pharmacokinetics of a vaginally administered formulation of progesterone. Am. J. Obstet. Gynecol., 1995; 173:471–477; discussion, 477–478.

Archer D. F. The effect of the duration of progestin use on the occurrence of endometrial cancer in postmenopausal women. Menopause, 2001; 8:245–251.

Arck P. Stress and embryo implantation. J. Gynecol. Obstet. Biol. Reprod., 2004; 33:S40-S42.

Armon L., Eisenbach M. Behavioral Mechanism during Human Sperm Chemotaxis: Involvement of Hyperactivation. PLoS ONE, 2011; 6 (12):e28359.

Arredondo F., Noble L. S. Endocrinology of recurrent pregnancy loss. Semin Reprod Med 2006; 24:33–39.

Arthur A. A., Daniel J. C. Progesterone regulation of blastokinin production and maintenance of rabbit blastocysts transferred into uteri of castrate recipients. Fert. Steril., 1972; 23:115–122.

Asso D. The Real Menstrual Cycle. New York: John Wiley & Sons; 1983.

Attia G. R., et al. Progesterone receptor isoform A but not B is expressed in endometriosis. J. Clin. Endocrinol. Metab., 2000; 85:2897–2902.

Aufrere M. B., Benson H. Progesterone: an overview and recent advances. J. Pharm. Sci. 1976; 65:783–800.

Aupperlee M., et al. Progestins and breast cancer. Breast Disease, 2005; 24:37–57.

Ayoubi J. M., et al. Uterorelaxing effects of vaginal progesterone: comparison of two methodologies for assessing uterine contraction frequency on ultrasound scans. Fertil. Steril., 2001; 76:736–740.

Azem F., et al. Does high serum progesterone level on the day of human chorionic gonadotropin administration affect pregnancy rate after intracytoplasmic sperm injection and embryo transfer? Gynecological Endocrinology, 2008; 24 (7):368–372.

Azziz R. PCOS: a diagnostic challenge. Reprod Biomed Online, 2004; 8:644–648.

Backer Jr. M. H. Isopregnenone (Duphaston): a new progestational agent. Obstet. Gynecol., 1962; 19:724–729.

Backstrom T., et al. Mood, sexuality, hormones and the menstrual cycle. II. Hormone levels and their relationship to the premenstrual syndrome. Psychosomatic Medicine, 1983; 45:503–507.

Baerwald A. R., Adams G. P., Pierson R. A. A new model for ovarian follicular development during the human menstrual cycle. Fertil. Steril., 2003; 80:116–122.

Bagga D., et al. Effects of a very low fat, high fiber diet on serum hormones and menstrual function: implications for breast cancer prevention. Cancer, 1995; 76:2491–2496.

Bahat A., et al. Thermotaxis of mammalian sperm cells: A potential navigation mechanism in the female genital tract. Nature Med., 2003; 9:149–150.

Baird D. D., et al. Application of a method for estimating day of ovulation using urinary estrogen and progesterone metabolites. Epidemiology, 1995; 6:547–550.

Baird D. D., et al. Using the ratio of urinary oestrogen and progesterone metabolites to estimate day of ovulation. Stat. Med., 1991; 10:255–266.

Bakker G. H., et al. Treatment of breast cancer with different antiprogestins: preclinical and clinical studies. Journal of Steroid Biochemistry and Molecular Biology, 1990; 37:789–794.

Bakos O., et al. Ultrasonographical and hormonal description of the normal ovulatory menstrual cycle. Acta Obstet. Gynecol. Scand. 1994; 73:790–796.

Balasch J. Sex steroids and bone: current perspectives. Hum. Reprod. Update, 2003; 9:207–222.

Baldi E., et al. Intracellular calcium accumulation and responsiveness to progesterone in capacitating human spermatozoa. J. Androl. 1991; 12:323–330.

Baldi E., et al. Nongenomic activation of spermatozoa by steroid hormones: facts and fictions. Mol. Cell Endocrinol., 2009; 308:39–46.

Baldi E., et al. Progesterone and spermatozoa: a long-lasting liaison comes to definition. Human Reproduction, 2011; 26 (11):2933–2934.

Ball B., Miller P., Daels P. Influence of exogenous progesterone on early embryonic development in the mare. Theriogenology, 1992; 38:1055–1063.

Baranczuk R. J., Fainstat T. Progesterone-induced ovulation of the hamster ovary in vitro. J. Endocrinol., 1976; 70:317–318.

Barnard K., et al. Health status among women with menstrual symptoms. Journal of Women’s Health, 2003; 12:911–919.

Barron A. M., Pike C. Sex hormones, aging, and Alzheimer’s disease. Front Biosci (Elite Ed), 2013; 4:976–997.

Baruffi R., et al. Effects of vaginal progesterone administration starting on the day of oocyte retrieval on pregnancy rates. J. Assist. Reprod. Genet., 2003; 20:517–520.

Baskin L. S., Himes K., Colborn T. Hypospadias and endocrine disruption: is there a connection? Environ Health Perspect, 2001; 109:1175–1183.

Bayard F., et al. Cytoplasmic and nuclear estradiol and progesterone receptors in human endometrium. J. Clin. Endocrinol. Metab., 1978; 46:635–648.

Bazer F. W., et al. Select nutrients, progesterone, and interferon tau affect conceptus metabolism and development. Ann. NY Acad. Sci., 2012; 1271:88–96.

Bazer F. W., Slayden O. D. Progesterone-induced gene expression in uterine epithelia: a myth perpetuated by conventional wisdom. Biol. Reprod., 2008; 79,1008–1009.

Beckmann M. W. et al. Influence of steroid hormones on 5 alpha-reductase activity in female and male genital skin fibroblasts in culture. Acta Endocrinol. (Copenh), 1993; 128:161–167.

Bedford J. M. Site of the mammalian sperm physiological acrosome reaction. Proc. Natl. Acad. Sci., USA, 2011; 108:4703–4704.

Bedu-Addo, et al. Mobilisation of stored calcium in the neck region of human sperm — a mechanism for regulation of flagellar activity. Int. J. Dev. Biol., 2008; 52:615–626.

Beir H. M. A hormone-sensitive endometrial protein in blastocysts development. Biochim. Biophys. Acta, 1968; 160:239–291.

Beleut M., et al. Two distinct mechanisms underlie progesterone-induced proliferation in the mammary gland. Proc. Natl. Acad. Sci., USA, 2010; 107:2989–2994.

Benagiano G., Bastianelli C., Farris M. Selective progesterone receptor modulators: use in oncology, endocrinology and psychiatry. Expert Opinion on Pharmacotherapy, 2008; 9:2487–2496.

Beral V., Bull D., Reeves G. Million Women Study Collaborators. Endometrial cancer and hormone-replacement therapy in the Million Women Study. Lancet, 2005; 365:1543–1551.

Beral V. Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet, 2003; 362:419–427.

Beral V. Million Women Study Collaborators. Ovarian cancer and hormone replacement therapy in the Million Women Study. Lancet, 2007; 369:1703–1710.

Bercovici J. P., Darragon T. Administration route of natural sex steroids (estradiol, progesterone, testosterone). Nouv Presse Med., 1980; 9:179–183.

Berga S., Naftolin F. Neuroendocrine control of ovulation. Gynecol. Endocrinol., 2012; 28 (S (1)):9–13.

Bergeron C. Morphological changes and protein secretion induced by progesterone in the endometrium during the luteal phase in preparation for nidation. Hum. Reprod., 2000;15:119–128.

Bergqvist A., Bergqvist D., Ferno M. Estrogen and progesterone receptors in vessel walls. Biochemical and immunochemical assays. Acta Obstet. Gynecol., 1993; 72:10–16.

Bergqvist A., Rybo G. Treatment of menorrhagia with intrauterine release of progesterone. Br. J. Obstet. Gynecol., 1983; 90:255–258.

Beta J., et al. Maternal Serum Progesterone-Induced Blocking Factor at 11–13 Weeks’ Gestation in Spontaneous Early Preterm Delivery. Fetal. Diagn.Ther., 2011; 29:197–200

Bhatia S. C., Bhatia S. K. Diagnosis and treatment of premenstrual dysphoric disorder. Am. Fam. Physician, 2002; 66 (7):1239–1248.

Biddie S. C, John S., Hager G. L. Genome-wide mechanisms of nuclear receptor action. Trends in Endocrinology and Metabolism, 2010; 21:3–9.

Bielefeldt K., Waite L., Abooud F., Conklin J. Nongenomic effects of progesterone on human intestinal smooth muscle cells. Am. J. Physiol., 1996; 271 (2 pt 1):G370–G376.

Biggers J. D., Borland R. M. Physiological aspects of growth and development of the preimplantation mammalian embryo. Ann. Rev. Physiol., 1976; 38:95–119.

Biggs W. S., Demuth R. H. Premenstrual Syndrome and Premenstrual Dysphoric Disorder. Am. Fam. Physician, 2011; 84 (8):918–924.

Biskind G. R., Glick D. Studies in histochemistry. V. The vitamin C concentration of the corpus luteum with reference to the stage of the estrous cycle and pregnancy. J. Biol. Chem., 1936; 27:113–134.

Bixo M., et al. Progesterone, 5-α-pregnane-3,20-dione and 3α-hydroxy-5-α-pregnane-20-one in specific regions of the human female brain in different endocrine states. Brain Research, 1997; 764 (1–2):173–178.

Blake E. J., et al. Single and multidose pharmacokinetic study of a vaginal micronized progesterone insert (Endometrin) compared with vaginal gel in healthy reproductive-aged female subjects. Fertil. Steril. Published online July 14, 2009.

Blengini C. S., et al. Human sperm pattern of movement during chemotactic re-orientation towards a progesterone source. Asian. Journal of Andrology, 2011; 13:769–773.

Bloch M., et al. Effects of gonadal steroids in women with a history of postpartum depression. Am. J. Psychiatry, 2000; 157:924–930.

Bloch M., Schmidt P. J., Rubinow D. R. Premenstrual syndrome: evidence for symptom stability across cycles. A. J. Psych., 1997; 154:1741–1746.

Blois S. M., et al. Depletion of CD8þ cells abolishes the pregnancy protective effect of progesterone substitution with dydrogesterone in mice by altering the Th1/Th2 cytokine profile. J. Immunol., 2004; 172:5893–5899.

Bogart M. H. Sex determination: a hypothesis based on steroid ratios. J. Theor. Biol., 1987; 128 (3):349–357.

Bonen A., et al. Effects of menstrual cycle on metabolic responses to exercise. J. Appl. Physiol. 1983; 55:1506–1513.

Boothby L. A., Doering P. L., Kipersztok S. Bioidentical hormone therapy: a review. Menopause, 2004; 11:356–367.

Boothby L. A., Doering P. L. Bioidentical hormone therapy: a panacea that lacks supportive evidence. Curr. Opin. Obstet. Gynecol., 2008; 20:400–407.

Borland R. M., Erickson G., Ducibella T. Accumulation of steroids in rabbit preimplantation blastocysts. J. Reprod. Fert., 1977; 49:219–224.

Borna S., Sahabi N. Progesterone for maintenance tocolytic therapy after threatened preterm labor: a randomized controlled trial. Aust. N. Z. J. Obstet. Gynecol., 2008; 48:58–63.

Borrelli P. T., et al. Human Chorionic Gonadotropin Isoform in the diagnosis of ectopic pregnancy. Clin. Chem., 2003:13.

Bosch E., et al. Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization — analysis of over 4000 cycles. Hum. Reprod. 2010; 25:2092–2100.

Bosch E., et al. Premature luteinisation during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome. Fertil. Steril., 2003; 80:1444–1449.

Bosch E. Comment on: is progesterone elevation on the day of human chorionic gonadotrophin administration associated with the probability of pregnancy in in vitro fertilization? A systematic review and meta-analysis. By Venetis et al. (2007). Hum. Reprod. Update, 2008; 14:194–5; author reply 195–196.

Bouckaert Y., et al. Acute eosinophilic pneumonia associated with intramuscular administration of progesterone as luteal phase support after IVF: case report. Hum. Reprod., 2004; 19:1806–1810.

Bowden H., Tesh J., Ross F. Effects of female sex hormones in whole embryo culture. Toxicol. In Vitro, 1993; 7:799–802.

Bowman P., McLaren A. Cleavage rate of mouse embryos in vivo and in vitro. J. Embryol. Exp. Morph., 1970; 24:203–207.

Brady B. M., et al. Demonstration of progesterone receptor-mediated gonadotrophin suppression in the human male. Clin. Endocrinol. (Oxf), 2003; 58:506–512.

Brandon D. D., et al. Progesterone receptor messenger ribonucleic acid and protein are over expressed in human uterine leiomyomas. Am. J. Obstet. Gynecol., 1993; 169:78–85.

Brent R. L. Nongenital malformations following exposure to progestational drugs: the last chapter of an erroneous allegation. Birth Defects Res. A Clin. Mol. Teratol., 2005; 73:906–918.

Brezina P. R., et al. The impact of luteal phase support on endometrial estrogen and progesterone receptor expression: a randomized control trial. Reprod. Biol. Endocrinol., 2012; 10:16.

Briggs M. H. Hypospadias, androgen biosynthesis, and synthetic progestogens during pregnancy. Int. J. Fertil., 1982; 27:70–72.

Brincat M., et al. Subcutaneous hormone implants for the control of climacteric symptoms. A prospective study. Lancet, 1984; 1:16–18.

Brinton R. D., et al. Progesterone receptors: form and function in brain. Front Neuroendocrinol, 2008; 29:313–339.

Britt K., Ashworth A., Smalley M.: Pregnancy and the risk of breast cancer. Endocr. Relat. Cancer, 2007; 14 (4):907–933.

Broekmans F. J. M., et al. The antral follicle count: practical recommendations for better standardization. Fertil. Steril., 2010; 94:1044–1051.

Brosens J. J., et al. Steroid receptor action. Best Practice and Research in Clinical Obstetrics and Gynecology, 2004; 18:265–283.

Brosens J. J., et al. A role for menstruation in preconditioning the uterus for successful pregnancy. Am. J. Obstet. Gynecol., 2009b; 200:615:e611–616.

Brosens J. J., et al. Proteomic analysis of endometrium from fertile and infertile patients suggests a role for apolipoprotein A-I in embryo implantation failure and endometriosis. Mol. Human. Reproduc., 2009a; 16:273–285.

Brosens J. J., et al. Steroid receptor action. Best practice and research clinical obstetrics and gynecology, 2004; 18:265–283.

Brosens J. J., Gellersen B. Death or survival — progesterone-dependent cell fate decisions in the human endometrial stroma. J. Mol. Endocrinol., 2006; 36:389–398.

Brosens J. J., Hayashi N., White J. O. Progesterone receptor regulates decidual prolactin expression in differentiating human endometrial stromal cells. Endocrinol., 1999; 140:4809–4820.

Brosens J. J., Pijnenborg R., Brosens I. A. The myometrial junctional zone spiral arteries in normal and abnormal pregnancies: a review of the literature. Am. J. Obstet, Gynecol., 2002; 187:1416–1423.

Brown A. J., et al. Progestin intrauterine device in an adolescent with grade 2 endometrial cancer. Obstet. Gynecol., 2012; 119 (2 Pt 2):423–426.

Buhrdel P., Willgerodt H., Theile H. Gestation time prolonging effect of progesterone and various synthetic gestagens in the rat]. Acta Biol. Med. Ger., 1974; 32:193–198.

Bulletti C., et al. Uterine contractility during the menstrual cycle. Hum. Reprod., 2000; 15:81–89.

Bulun S., et al. Progesterone resistance in endometriosis: Link to failure to metabolize estradiol. Mol. Cell. Endocrinol., 2006 248:94–103.

Bulun S. E. Endometriosis. New England Journal of Medicine, 2009; 360:268–279.

Burger H. G., et al. A review of hormonal changes during the menopausal transition: focus on findings from the Melbourne Women’s Midlife Health Project. Hum. Reprod. Update, 2007; 13:559–565.

Burkman L. J. Characterization of hyperactivated motility by human spermatozoa during capacitation: comparison of fertile and oligozoospermic sperm populations. Arch. Androl. 1984; 13:153–165.

Burney R. O., et al. Gene expression analysis of endometrium reveals progesterone resistance and candidate susceptibility genes in women with endometriosis. Endocrinol., 2007; 148:3814–3826.

Burstein R., Wasserman H. C. The effect of provera on the fetus. Obstet. Gynecol., 1964; 23:931–934.

Busacca M., Vignali M. Endometrioma Excision and Ovarian Reserve: A Dangerous Relation. Journal of Minimally Invasive Gynecology, 2009; 16:142–148.

Butenandt A., Westphal U. Zur Isolierung und Charakterisierung des Corpus luteum Hormons. Berichte Deu0tsche chemische Gesellschaft, 1934; 67 (8):1440–1442.

Buvat J., et al. Luteal support after luteinizing hormone releasing hormone agonist for in vitro fertilization; superiority of human chorionic gonadotropin over oral progesterone. Fertil. Steril., 1990; 53:490–494.

Calaf G. M. Susceptibility of human breast epithelial cells in vitro to hormones and drugs. International. J. Oncol., 2006; 28:285–295.

Calzolari E., et al.Aetiological factors in hypospadias. J. Med. Genet., 1986; 23:333–337.

Cameron I. T., Irvine G., Norman J. E. Menstruation. In Scientific essentials of reproductive Medicine, Eds SG Hiller, HC Kitchener and JP Neilson. London: W.B.Saunders, 1996.

Campagnoli C., et al. Progestins and progesterone in hormone replacement therapy and the risk of breast cancer. J. Steroid. Biochem. Mol. Biol., 2005; 96:95–108.

Canfield R. E., et al. Development of an assay for a biomarker of pregnancy and early fetal loss. Environ Health Perspec, 1987; 74:57–66.

Canonico M., et al. Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens. Circulation, 2007; 115 (7):840–5.

Carmichael S. L., et al. Maternal progestin intake and risk of hypospadias. Arch. Pediatr. Adolesc. Med., 2005; 159:957–962.

Carp H. Cytokines in recurrent miscarriage. Lupus, 2004; 13:630–634.

Carson-Jurica M. A., Schrader W. T., O’Malley B. W. Steroid receptor family: structure and functions. Endocr. Rev., 1990; 11:201–220.

Case A. M., Reid R. L. Effects of the menstrual cycle on medical disorders. Arch. Inter. Med., 1998; 158:1405–1412.

Casey M. L., MacDonald P. C. Formation of deoxycorticosterone from progesterone in extraadrenal tissues: demonstration of steroid 21-hydroxylase activity in human aorta. J. Clin. Endocrinol. Metab., 1982; 55:804–806.

Casey M. L., Winkel C. A., MacDonald P. C. Conversion of progesterone to deoxycorticosterone in the human fetus: steroid 21-hydroxyase activity in fetal tissues. J. Steroid. Biochem., 1983; 18:449–452.

Cassidenti D. L., et al. Ef fects of sex steroids on skin 5 alpha-reductase activity in vitro. Obstet. Gynecol., 1991; 78:103–107.

Casson P., et al. Lasting response to ovariectomy in severe intractable premenstrual syndrome. Am. J. Obstet. Gynecol., 1990; 162:99–105.

Catt K. J. ABC of endocrinology. I. Hormones in general. Lancet, 1970; 1:763–765.

Caufriez A., et al. Progesterone Prevents Sleep Disturbances and Modulates GH, TSH, and Melatonin Secretion in Postmenopausal Women. J. Clin. Endocrinol. Metab., 2011;96:E614–E623.

Cauley J. A., et al. Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women’s Health Initiative randomized trial. JAMA, 2003; 290:1729–1738.

Cavagna M., Mantese J. C. Biomarkers of endometrial receptivity — a review. Placenta, 2003; 24 (Suppl B):S39–S47.

Celayir S., Ilce Z., Dervisoglu S. The sex hormone receptors in the bladder in childhood, I: preliminary report in male subjects. Eur. J. Pediatr. Surg., 2002; 12:312–317.

Chabbert-Buffet N., et al. Selective progesterone receptor modulator and progesterone antagonist: mechanism of action and clinical application. Hum. Reprod. Update, 2005; 11:293–307.

Chaffin C. L., Hess D. L., Stouffer R. L. Dynamics of periovulatory steroidogenesis in the rhesus monkey follicle after controlled ovarian stimulation. Hum. Reprod., 1999; 14:642–649.

Chaffin C. L., Stouffer R. L. Expression of matrix metalloproteinases and their tissue inhibitor messenger ribonucleic acids in macaque periovulatory granulose cells: time course and steroid regulation. Biology of Reproduction, 1999; 61:14–21.

Champagne J., et al. Progesterone and Cerebral Function during Emotion Processing in Men and Women with Schizophrenia. Hindawi Publishing Corporation, Schizophrenia Research and Treatment, 2012; 6.

Chang R. J. Polycystic ovaries in 2001:physiology and treatment. J. Gynecol. Obstet. Biol. Reprod. (Paris), 2002; 31:1S15–1S19.

Channing C. P., et al. Hormonal control of oocyte meiosis, ovulation and luteinization in mammals. Clin. Endocrinol. Metab., 1978; 7 (3):601–24.

Channing C. P., et al. Ovarian follicular and luteal physiology. Int. Rev. Physiol.,1980; 22:117–201.

Chantilis S. J., et al. Use of Crinone vaginal progesterone gel for luteal support in in vitro fertilization cycles. Fertil. Steril., 1999; 72:823–829.

Chao K. H., et al. Decidual natural killer cytotoxity decreased in normal pregnancy but not in anembryonic pregnancy and recurrent spontaneous abortion. Am. J. Reprod. Immunol., 1995; 34:274–280.

Chaouat G., et al. A brief review of recent data on some cytokine expressions at the materno-foetal interface that might challenge the classical Th-1/Th-2 dichotomy. J. Reprod. Immunol., 2002; 53:241–256.

Charlesworth D. Plant sex determination and sex chromosomes. Heredity, 2002; 88:94–101.

Check J. H., et al. Evidence that high serum progesterone (P) levels on day of human chorionic gonadotropin (hCG) injection have no adverse effect on the embryo itself as determined by pregnancy outcome following embryo transfer using donated eggs. Clin. Exp. Obstet. Gynecol., 2010; 37:179–180.

Check J. H., et al. Pregnancy rates in donors versus recipients according to the serum progesterone level at the time of human chorionic gonadotropin in a shared oocyte program. Fertil. Steril., 1994; 61:262–264.

Check J. H., et al. Progesterone therapy to decrease first-trimester spontaneous abortions in previous aborters. Int. J. Fertil., 1987; 33:192–199.

Check J. H., Rankin A., Teichman M. The risk of fetal anomalies as a result of progesterone therapy during pregnancy. Fertil. Steril., 1986; 45:575–577.

Check J. H. Th1 and Th2 cytokine profiles in recurrent aborters may merely reflect progesterone status. Hum. Reprod., 2002; 17:1669–1674.

Cheng C. M., et al. Estrogen augments glucose transporter and IGF1 expression in primate cerebral cortex. FASEB J., 2001; 15:907–915.

Cheremisinoff N. P., King J. A., Boyko R. Dangerous Properties of Industrial and Consumer Chemicals. M. Dekker, 1994:779.

Chetkowski R. J., Kiltz R. J., Salyer W. R. In premature luteinization, progesterone induces secretory transformation of the endometrium without impairment of embryo viability. Fertil. Steril., 1997; 68:292–297.

Chhabra S., et al. Progesterone inhibition of the hypothalamic gonadotropinreleasing hormone pulse generator: evidence for varied effects in hyperandrogenemic adolescent girls. J. Clin. Endocrinol. Metab., 2005; 90:2810–2815.

Chlebowski R. T., et al. Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women. JA MA,2010; 304:1684–1692.

Choi B. C., et al. Progesterone inhibits in vitro embryotoxic Th1 cytokine production to trophoblast in women with recurrent pregnancy loss. Hum. Reprod., 2000; 15:46–59.

Chrisler J. C., Caplan P. The strange case of Dr. Jekyll and Ms. Hyde: how PMS became a cultural phenomenon and a psychiatric disorder. Annual Review of Sex Research, 2002; 13:274–306.

Christian M., et al. Mechanisms of decidualization. Reproductive Biomedicine. Online, 2002a; 4 (Suppl. 3):24–30.

Christiansen O. B., et al. Evidence-based investigations and treatments of recurrent pregnancy loss. Fertil. Steril., 2005; 83:821–839.

Christiansen O. B. A fresh look at the causes and treatment of recurrent miscarriage, especially its immunological aspects. Hum. Reprod. Update, 1996; 2:271–293.

Christow A., Sun X., Gemzell-Danielsson K. Effect of mifepristone and levonorgestrel on expression of steroid receptors in the human Fallopian tube. Mol. Hum. Reprod., 2002;8:333–340.

Chumlea W. C., et al. Age at menarche and racial comparisons in US girls.Pediatrics, 2003; 111:110–113.

Chwalisz K., et al. Selective progesterone receptor modulator development and use in the treatment of leiomyomata and endometriosis. Endocrine Reviews, 2005; 26:423–438.

Cicinelli E., et al. Direct transport of progesterone from vagina to uterus. Obstet. Gynecol., 2000; 95:403–406.

Cicinelli E., et al. Effects of progesterone administered by nasal spray on the human postmenopausal endometrium. Maturitas, 1993; 18:65–72.

Cicinelli E., et al. Effects of the repetitive administration of progesterone by nasal spray in postmenopausal women. Fertil. Steril., 1993; 60:1020–1024.

Cirigliano M. Bioidentical hormone therapy: a review of the evidence. J. Womens Health (Larchmt), 2007; 16:600–631.

Clark C. L., Sutherland R. L. Progestin regulation of cellular proliferation. Endocrine Review, 1990; 11:266–301.

Clark D. A., Arck P. C., Chaouat G. Why did your mother reject you? Immunogenetic determinants of the response to environmental selective pressure expressed at uterine level. Am. J. Reprod. Immunol., 1999; 41:5–22.

Clark D. A., et al. The emerging role of immunoregulation of fibrinogen-related procoagulant Fgl2 in the success or spontaneous abortion of early pregnancy in mice and humans. Am. J. Reprod. Immunol., 1999; 42:37–42.

Clark D. A., et al. Unexplained sporadic and recurrent miscarriage in the new millenium: a critical analysis of immune mechanisms and treatments. Hum. Reprod. Update, 2001; 7:501–511.

Clark R. Endpoints of reproductive system development. An evaluation and interpretation of reproductive endpoints for human health risk assessment. Washington, DC: International Life Sciences Institute, 1998; 10–27.

Clarke C. L., Sutherland R. L. Progestin regulation of cellular proliferation. Endocr. Rev., 1990; 11:266–301.

Clauberg C. Physiologie und Pathologie der Sexualhormone, im Besonderen des Hormons des Corpus luteum. I. Der biologische Test fu¨r das Luteumhormon (das spezielle Hormon des Corpus luteum) am infantilen Kaninchen. Z. Gyna¨kol., Leipzig, 1930; 54:2757–2770.

Clausen H. Effect of progesterone and desoxycorticosterone on accessory sex organs of the castrate male guinea pig. Endocrinol., 1942; 31:187–190.

Clifford K., Flanagan A. M., Regan L. Endometrial CD56þ natural killer cells in women with recurrent miscarriage: a histomorphometric study. Hum. Reprod.,1999; 14:2727–2730.

Clifford K., Rai R., Regan L. Future pregnancy outcome in unexplained recurrent first trimester miscarriage. Hum. Reprod., 1997; 12:387–389.

Cloke B., et al. The androgen and progesterone receptors regulate distinct gene networks and cellular functions in decidualizing endometrium. Endocrinol., 2008; 149:4462–4474.

Cocuroccia B., et al. Autoimmune progesterone dermatitis Gynecol. Endocrinol., 2006; 22 (1):54–56.

Colditz G. A., et al. Risk factors for breast cancer according to estrogen and progesterone receptor status. J. Natl. Cancer Inst., 2004; 96:218–228.

Cole L. A., et al. Hyperglycosylated hCG (invasive trophoblast antigen, ITA) a key antigen for early pregnancy detection. Clin. Biochem., 2003; 36:647–655.

Cole L. A. Predicting spontaneously aborted (SAB) pregnancies. human chorionic gonadotropin (hCG). Elsevier Inc., 2010; 287–294.

Conaway E. Bioidentical Hormones: An Evidence-Based Review for Primary Care Providers. J. Am. Osteopath. Assoc., 2011; 111 (3):153–164.

Conneely O. M., Habenicht U. F., Aitken R. J. (eds.). Progesterone Receptors and Ovulation. Fertility Control, Handbook of Experimental Pharmacology 198, Springer Verlag Berlin Heidelberg, 2010: 37–44.

Conneely O. M., et al. Reproductive functions of progesterone receptors. Recent Prog. Horm. Res., 2002; 57:339–355.

Conneely O. M., et al. Reproductive functions of the progesterone receptor isoforms: lessons from knock-out mice. Mol. Cell. Endocrinol., 2001; 179:97–103.

Conneely O. M., Jericevic B. M., Lydon J. P. Progesterone receptors in mammary gland development and tumorigenesis. J. Mamm. Gland. Biol. Neoplas., 2003a; 8:205–214.

Conneely O. M., Lydon J. P. Progesterone receptors in reproduction: functional impact of the A and B isoforms. Steroids, 2000; 65:571–577.

Conneely O. M., Mulac-Jericevic B., Lydon J. P. Progesterone-dependent regulation of female reproductive activity by two distinct progesterone receptor isoforms. Steroids, 2003b; 68:771–778.

Coomarasamy A., et al. Progesterone for the prevention of preterm birth: a critical evaluation of evidence. Eur. J. Obstet. Gynecol. Reprod. Biol., 2006; 129:111–118.

Cooper A., et al. Systemic absorption of progesterone from Progest cream in postmenopausal women [letter]. Lancet, 1998; 351:1255–1256.

Corner G. W., Allen W. M. Physiology of the corpus luteum. Am J Physiol 1929;88:326–346.

Coutifaris C., et al. Histological dating of timed endometrial biopsy tissue is not related to fertility status. Fertil Steril 2004;82:1264–1272.

Cowan B. D., Manes C., Hagerman D. D. Progesterone concentration in rabbit uterine flushings before implantation. J. Reprod. Fert., 1976; 47:359–361.

Cramer D. W., et al. Human progesterone receptor polymorphisms and implantation failure during in vitro fertilization. Am. J. Obstet. Gynecol., 2003; 189:1085–1092.

Critchley H. O., et al. Antiprogestins as a model for progesterone withdrawal. Steroids, 2003; 68:1061–1068.

Critchley H. O., et al. Role of inflammatory mediators in human endometrium during progesterone withdrawal and early pregnancy. J. Clin. Endocrino. Metab., 1999; 84:240–248.

Critchley H. O., et al. Sex steroid regulation of leukocyte traffic in human decidua. Hum. Reprod. 1996; 11:2257–2262.

Critchley O. D., Healy D. L. Effects of estrogens and progesterone on the endometrium. In: Estrogens and progestogens in clinical practice, pp. 145–161. Ed. Ian S.Fraser. London, UK: Churchill Livingstone, 1998.

Crombie D. L., et al. Anti-progesterone effects on maternal recognition and behaviour imprinted during first pregnancy in mice. J. Endocrinol., 1995; 147:331–337.

Cronje W. H., Vashisht A., Studd J. W. Hysterectomy and bilateral oophorectomy for severe premenstrual syndrome. Hum. Reprod., 2004; 19:2152–2155.

Crosby T. F., et al. Effects of exogenous progesterone on gestation length, foetal survival and colostrum yield in ewes. Theriogenology, 2005; 64:1121–1129.

Crow J., et al. Mast cells in the female genital tract. Int. J. Gynecol. Pathol., 1991; 10:230–237.

Croxatto H. B., Diaz S. The place of progesterone in human contraception. J. Steroid Biochem., 1987; 27:991–994.

Csapo A. I., et al. The significance of the human corpus luteum in pregnancy maintenance. I. Preliminary studies. Am. J. Obstet. Gynecol., 1972; 112:1061–1067.

Csapo A. I., Pulkkinen M. O., Kaihola H. L. The effect of luteectomy-induced progesterone-withdrawal on the oxytocin and prostaglandin response of the first trimester pregnant human uterus. Prostaglandins, 1973; 4:421–429.

Csapo A. I., Pulkkinen M. O., Wiest W. G. Effect of luteectomy and progesterone replacement therapy in early pregnant patient. Am. J. Obstet. Gynecol., 1973; 115:759–765.

Csapo A. I., Resch B. Prevention of implantation by antiprogesterone. J. Steroid Biochem., 1979; 11:963–969.

Csapo A. I. The «ovariectomy syndrome» and the initiation of labor: International Symposium on Prenatal Life: Biological and Clinical Prospectives. Detroit: Thomas; 1967.

Csapo A. I. The luteo-placental shift: the guardian of prenatal life. Postgrad. Med. J., 1969; 45:57–64.

Cumming D. C., et al. The late luteal phase in infertile women: comparison of simultaneous endometrial biopsy and progesterone levels. Fertil. Steril., 1985; 43:715–719.

Current National legislation relationg to use of certain hormones in animal production. http://www.fao.org/docrep/004/X6533E/X6533E03.htm

Curry T. E. Jr., Osteen K. G. The matrix metalloproteinase system: changes, regulation, and impact throughout the ovarian and uterine reproductive cycle. Endocrine Review, 2003; 24:428–465.

Czeizel A., Toth J., Erodi E. Aetiological studies of hypospadias in Hungary. Hum. Hered., 1979; 29:166–171.

Czeizel A., Toth J. Correlation between the birth prevalence of isolated hypospadias and parental subfertility. Teratology, 1990; 41:167–172.

da Fonseca E. B., Damião R., Nicholaides K. Prevention of Preterm Birth Based on Short Cervix: Progesterone. Semin. Perinatol., 2009; 33:334–337.

da Fonseca E. B., et al. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am. J. Obstet. Gynecol., 2003; 188:419–424.

Dahmoun M., et al. Apoptosis, proliferation, and sex hormone receptors in superficial parts of human endometrium at the end of the secretory phase. J. Clin. Endocrinol. Metab., 1999; 84:1737–1743.

Dal Prato L., Borini A. Use of antagonists in ovarian stimulation protocols. Reprod. Biomed. Online, 2005; 10:330–338.

Dalton K. Ante-natal Progesterone and Intelligence. BJP, 1968; 114:1377–1382.

Dalton K. Prenatal progesterone and educational attainments. BJP, 1976; 129:438–442.

Daneshmand S., et al. Very early hCG dynamics predict pregnancy loss at up to 10 weeks gestation. Fertil. Steril., 2007; 88:S159.

Danilenko K., Sergeeva O., Verevkin E. Menstrual cycles are influenced by sunshine. Gynecol. Endocrinol., 2011; 27 (9):711–716.

Das R. M., Martin L. Progesterone inhibition of mouse uterine epithelial proliferation. J. Endocrinol. 1973; 59:205–206.

Davies J., Kadir R. A. Endometrial haemostasis and menstruation. Rev. Endocr. Metab. Disord., 2012; 13:289–299.

Davison S. Salivary testing opens a Pandora’s box of issues surrounding accurate measurement of testosterone in women. Menopause, 2009; 16:630–631.

Dawood M. Y. Corpus luteal insufficiency. Curr. Opin. Obstet. Gynecol., 1994; 6:121–127.

Dawson R. F. Diosgenin Production in North America: A Brief History. American Society for Horticultural Science. HortTechnology, 1991; 1:22–27.

Daya S., Gunby J. Luteal phase support in assisted reproduction cycles. Cochrane Database Syst. Rev., 2004; 3:CD004830.

Daya S. Efficacy of progesterone support for pregnancy in women with recurrent miscarriage. A meta-analysis of controlled trials. Br. J. Obstet. Gynecol., 1989; 96:257–260.

Daya S. Evaluation and management of recurrent spontaneous abortion. Curr. Opin. Obstet. Gynecol., 1993; 8:188–192.

Daya S. Human chorionic gonadotropin increase in normal early pregnancy. Am. J. Obstet. Gynecol., 1987; 156:286–290.

Daya S. Immunotherapy for unexplained recurrent spontaneous abortion. Infertil. Reprod. Med. Clin. North. Am., 1997; 8:65–77.

Daya S. Issues in the etiology of recurrent spontaneous abortion. Curr. Opin. Obstet. Gynecol., 1994; 6:153–159.

De Geyter, et al. Progesterone serum level during the follicular phase of the menstrual cycle originate from crosstalk between the ovaries and adrenal cortex. Human Reproduction, 2002; 17:4:933–939.

De Lignieres B., et al. Indluence of route administration on progesterone metacolism. Maturitas, 1995; 21:251–257.

de Lignieres B. Oral micronized progesterone. Clin. Ther., 1999; 21:41–60; discussion 1–2.

De Souza A., et al. Genital anomalies with maternal exposure to progesterone in mice. American Urological Society Annual Meeting, San Francisco, May 8–13, 2004.

De Vivo I., et al. A functional polymorphism in the promoter of the progesterone receptor gene associated with endometrial cancer risk. Proc. Natl. Acad. Sci. USA, 2002; 99:12263–12268.

Dean H. J., Winter J. S. The effect of five synthetic progestational compounds on 5-alpha-reductase activity in genital skin fibroblast monolayers. Steroids, 1984; 43:13–24.

DeFranco E. A., et al. Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double-blind, placebo-controlled trial. Ultrasound Obstet. Gynecol., 2007;30:697–705.

Dennerstein L., et al. Mood and the menopausal transition. J. Nerv. Ment. Dis.,1999;187:685–691.

Dennis C. L., Ross L. E., Herxheimer A. Oestrogens and progestins for preventing and treating postpartum depression. Cochrane Database Syst. Rev., 2008; 4:CD001690.

Derry P. S., Derry G. N. Menstruation, Perimenopause, and Chaos Theory. Perspectives in Biology and Medicine, 2012; 55 (1):26–42.

Desreux J., et al. Progesterone receptor activation: an alternative to SERMs in breast cancer. Eur. J. Cancer, 2000; 36 (sup. 4):90–91.

Dey S. K., et al. Molecular cues to implantation. Endocrine Reviews, 2004; 25:341–373.

Di Carlo C., et al. Use of leuprolide acetate plus tibolone in the treatment of severe premenstrual syndrome. Fertil. Steril., 2001; 76:850–852.

Di Paolo T., et al. Effect of acute and chronic 17-beta-estradiol treatment on serotonin and 5-hydroxyindole acetic acid content of discrete brain nuclei of ovariectomized rat. Exp. Brain. Res., 1983; 51:73–76.

Di Renzo G. C., et al. Progesterone and pregnancy. Curr. Opin. Obstet. Gynecol., 2005; 17: 589–600.

Di Renzo G. C., et al. The role of progesterone in maternal and fetal medicine. Gynecol. Endocrinol., 2012; 28 (11):925–932.

Di Zerega G. S., Hodgen G. D. Folliculogenesis in the primate ovarian cycle. Endocr. Rev., 1981; 2:27–49.

Diamond M., LLacuna A., Wong C. L. Sex behavior after neonatal progesterone, testosterone, estrogen, or antiandrogens. Horm. Behav., 1973; 4:73–88.

Dickens C. Household words. 1852; 95:385–389.

Dilley A., et al. von Willebrand disease and other inherited bleeding disorders in women with diagnosed menorrhagia. Obstet. Gynecol., 2001; 97:630–636.

Ding Y. Q., et al. Progesterone stimulates calcitonin gene expression in the uterus during implantation. Endocrinol., 1994; 135:2265–2274.

Dodd J. M., et al. Prenatal administration of progesterone for preventing preterm birth [review]. Cochrane Database Syst. Rev., 2006; 2:CD004947.

Dodd J. M., et al. Progesterone for the prevention of preterm birth. Obstet. Gynecol., 2008; 112:127–134.

Dodd J. M., et al. Progesterone supplementation for preventing preterm birth: a systematic review and meta-analysis. Acta Obstet Gynecol Scand 2005;84:526–533.

Doglioni C, et al. Immunocytochemical localization of progesterone receptors in endocrine cells of the human pancreas. Am. J. Pathol., 1990; 137:999–1005.

Doldi N., et al. Polycystic ovary syndrome: anomalies in progesterone production. Hum. Reprod., 1998; 13:290–293.

Domenice S., et al. Mutations in the SRY, DAX1, SF1 and WNT4 genes in Brazilian sex-reversed patients. Braz. J. Med. Biol. Res., 2003; 36 (12):145–150.

Dong Y. L., et al. Regulation of inducible nitric oxide synthase messenger ribonucleic acid expression in pregnant rat uterus. Biol. Reprod., 1998; 59:933–940.

Donnet M. L., et al. Return of ovarian function following spontaneous abortion. Clin. Endocrinol. (Oxf.), 1990; 33:13–20.

Doody K. J., et al. Endometrin for luteal phase support in a randomized, controlled, open-label, prospective IVF clinical trial using a combination of Menopur and Bravelle. Fertil. Steril., 2009; 91:1012–1017.

Doyle E. FRI Briefings, Human safety of hormone implants used to promote growth in cattle. Food Research Institute, University of Wisconsin, Madison, 2000.

Dressing G. E., et al. Progesterone receptors act as sensors for mitogenic protein kinases in breast cancer models. Endocrine Related Cancer, 2009; 16:351–361.

Druckmann R., Druckmann M. A. Progesterone and the immunology of pregnancy. J. Steroid. Biochem. Mol. Biol., 2005; 97:389–396.

Drummond-Robinson G., Asdell S. A. The relation between the corpus luteum and the mammary glan. J. Physiol., 1926, August 6; 61 (4):608–614.

Dube J., Ngo-Thi N., Tremblay R. In vivo effects of steroid hormones on the testosterone 5-alpha-reductase in rat skin. Endocrinol., 1975; 97:211–214.

Duggavathi R., Murphy D. B. Ovulation Signals. Science, 2009; 324:890–891.

Dutt R. H., Casida L. E. Alteration of the estrual cycle in sheep by use of progesterone and its effect upon subsequent ovulation and fertility. Endocrin., 1948; 43:208.

Eblen A. C., et al. Alterations in humoral immune responses associated with recurrent pregnancy loss. Fertil. Steril., 2000; 73:305–313.

Echternkamp S. E., Lunstra D. D. Relationship between LH and testicular development in progesterone-implanted prepubertal ram lambs. J. Anim. Sci., 1984; 59:441–453.

Edefonti V., et al. Nutrient dietary patterns and the risk of breast and ovarian cancers. Int. J. Cancer, 2008; 122:609–613.

Edelstein M. C., et al. Progesterone levels on the day of human chorionic gonadotropin administration in cycles with gonadotropin-releasing hormone agonist suppression are not predictive of pregnancy outcome. Fertil. Steril., 1990; 54:853–857.

Edgren R. A., Stanczyk F. Z. Nomenclature of the Gonane Progestins. Contraception, 1999; 60 (6):313.

Edlund M., Andersson E., Fried G. Progesterone withdrawal causes endothelin release from cultured human uterine microvascular endothelial cells. Hum. Reprod., 2004; 19 (6):1272–1280.

Edson M. A. et al. The mammalian ovary from genesis to revelation. Endocrine Reviews, 2009; 30 (6):624–712.

Eisenbach M., Giojalas L. C. Sperm guidance in mammals — an unpaved road to the egg. Nature Rev. Mol. Cell. Biol., 2006; 7:276–285.

Eldred S. M. Menstruation Myths. New Moon, 1998; 5.6:40.

Elovainio M., et al. Depressive symptoms as predictors of discontinuation of treatment of menorrhagia by levonorgestrel-releasing intrauterine system. Int. J. Behav. Med., 2007; 14:70–75.

El-Zibdeh M. Y. Dydrogesterone in the reduction of recurrent spontaneous abortion. J. Steroid. Biochem. Mol. Biol., 2005; 97:431–434.

Emera D., Romero R., Wagner G. The evolution of menstruation: A new model for genetic assimilation. Bioessays, 2011; 34: 26–35.

Endocrine Society. Bioidentical hormones: position statement. 2006. http://www.endosociety.org/advocacy/policy

Ericson A., Kallen B. Congenital malformations in infants born after IVF: a population-based study. Hum. Reprod., 2001; 16:504–509.

Ertman N., Andreano J. M, Cahill L. Progesterone at encoding predicts subsequent emotional memory. Learn Mem., 2011; 18:759–763.

Esplin M. S., et al. Estimating recurrence of spontaneous preterm delivery. Obstet. Gynecol., 2008 112 (3):516–523.

Evans J., Salamonsen L. A. Inflammation, leukocytes and menstruation. Rev. Endocr. Metab. Disord., 2012; 13:277–288.

Evans R. M. The steroid and thyroid hormone receptor superfamily. Science, 1988; 240:889–895.

Facchinetti F., et al. Cervical length changes during preterm cervical ripening: effects of 17-alpha-hydroxyprogesterone caproate. Am. J. Obstet. Gynecol., 2007; 196 (5):453.e1–453.e4.

Falsetti C., et al. Decreased responsiveness to progesterone of spermatozoa in oligozoospermic patients. J. Androl., 1993; 14:17–22.

Fanchin R., et al. Transvaginal administration of progesterone. Obstet. Gynecol., 1997; 90:396–401.

Fanchin R., et al. Hormonal influence on the uterine contractility during ovarian stimulation. Hum. Reprod., 2000; 15:90–100.

Fanchin R., et al. Uterine contractions at the time of embryo transfer alter pregnancy rates after in-vitro fertilization. Hum. Reprod.,1998; 13:1968–1974.

Fanhin R., et al. Premature elevation of plasma progesterone alters pregnancy rates of in vitro fertilization and embryo transfer. Fertil. Steril., 1993; 59:1090–1094.

Farine D., Mundle W. R., Dodd J. The use of progesterone for prevention of preterm birth. J. Obstet. Gynecol. Can., 2008; 30:67–71.

Farquaharson R. G., Klopper A. I. Progesterone concentrations in maternal and fetal blood. BJOG, 1984; 91:133–137.

Fatemi H. M., et al. An update of luteal phase support in stimulated IVF cycles. Hum. Reprod. Update, 2007; 13:581–590.

Fauser B. C., Devroey P. Reproductive biology and IVF: ovarian stimulation and luteal phase consequences. Trends Endocrinol. Metab., 2003; 14:236–242.

Faust Z., et al. Progesterone induced blocking factor inhibits degranulation of NK cells. Am. J. Reprod. Immunol., 1999; 42:71–75.

Fazleabas A. T. Progesterone resistance in a baboon model of endometriosis. Sem. Reproduc. Med., 2010; 28:75–80.

Fechner P. Y., et al. The role of the sex-determining region Y gene in the etiology of 46,XX maleness. J. Clinical Endocrine Metabolism, 1993; 76:690–695.

Ferencz C., et al. Maternal hormone therapy and congenital heart disease. Teratology, 1980; 21:225–239.

Ferin M. Neuroendocrine control of ovarian function in the primate. J. Reprod. Fertil., 1983; 69:369–81.

Ferre F., et al. Oral administration of micronized natural progesterone in late human pregnancy. Effects on progesterone and estrogen concentrations in the plasma, placenta, and myometrium. Am. J. Obstet. Gynecol., 1984; 148:26–34.

Ferretti G., Felici A., Cognetti F. The protective side of progesterone. Breast Cancer Research, 2007; 9:402.

Fetal effects of exogenous progesteroine. Birth Defects Research (Part B), 2006; 77:455–470.

Fiad T. M., Cunningham S. K., McKenna T. J. Role of P deficiency in the development of luteinizing hormone and androgen abnormalities in polycystic ovary syndrome. Eur. J. Endocrinol., 1996; 135:335–339.

Files J. A., Ko M. G., Pruthi S. Bioidentical Hormone Therapy Concise review for clinicians. Mayo Clin. Proc., 2011; 86 (7):673–680.

Filicori M., Butler J. P., Crowley W. F. Jr. Neuroendocrine regulation of the corpus luteum in the human. Evidence for pulsatile progesterone secretion. J. Clin. Invest., 1984; 73:1638–1647.

Fisch H., et al. Maternal age as a risk factor for hypospadias. J. Urol., 2001; 165:934–936.

Fitzpatrick L. A., Good A. Micronized progesterone: clinical indications and comparison with current treatments. Fertil. Steril., 1999; 72:389 –97.

Fitzpatrick L. A., Pace C., Wiita B. Comparison of regimens containing oral micronized progesterone or medroxyprogesterone acetate on quality of life in postmenopausal women: a cross-sectional survey. J. Womens Health Gend. Based Med., 2000; 9 (4):381–7.

Fleming R., et al. Spontaneous follicular and luteal function in infertile women with oligomenorrhoea: role of luteinizing hormone. Clin. Endocrinol. (Oxf), 1995; 43:735–739.

Fomin V., Cox B., Word R. Effect of progesterone on intracellular Ca (2+) homeostasis on human myometrial smooth muscle cells. Am. J. Physiol., 1999; 276 (2, pt.1):C379–C385.

Fonseca E. B., et al. Fetal Medicine Foundation Second Trimester Screening Group. Progesterone and the risk of preterm birth among women with a short cervix. N. Engl. J. Med., 2007; 357 (5):462–469.

Food and Drug Administration. Bio-identicals: sorting myth from fact. US Food and Drug Administration. Web site. http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm049311.htm.

Food and Nutrition Board. Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids (macronutrients). Washington, DC: Institute of Medicine, 2005.

Foote W., Foote L. Influence of certain natural and synthetic steroids on genital development in guinea pigs. Fertil. Steril., 1964; 19:606–615.

Ford O., et al. Progesterone for premenstrual syndrome. Cochrane Database of Systematic Reviews, 2009. Issue 2. Art. No.:CD003415.

Fournier A., et al. Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort. Int. J. Cancer, 2005; 114 (3):448–54.

Fowler R. E., et al.The progesterone content of rabbit uterine flushings. J. Reprod. Fert., 1977; 50:301–308.

Fraenkel L. Die Function des Corpus Luteum, Arch. f.Gyn, 1903; 68:438.

Franchimont P., et al. Correlation between follicular fluid content and the results of in vitro fertilization and embryo transfer. I. Sex steroids. Fertil. Steril., 1989; 52:1006–1011.

Franco H. L., et al. In vivo analysis of progesterone receptor action in the uterus during embryo implantation. Seminars in Cell & Developmental Biology, 2008; 19:178–186.

Frank R. T. The Ovary and the Endocrinologist. JAMA, 1922; 78:181.

Freedman D. S., et al. Relation of age at menarche to race, time period, and anthropometric dimensions: the Bogalusa Heart Study. Pediatrics, 2002; 110:e43.

Freeman E. W. Premenstrual syndrome and premenstrual dysphoric disorder: definitions and diagnosis. Psychoneuroendocrinology, 2003; 28:25–37.

Friedler S., et al. Luteal phase characteristics following GnRH antagonist or agonist treatment — a comparative study. Reprod. Biomed., Online, 2006; 12:27–32.

Friedman C. I., Kim M. H. Obesity and its effect on reproductive function. Clin. Obstet. Gynecol., 1985; 28:645–663.

Frisch R. E., Revelle R. Height and weight at menarche and a hypothesis of critical body weights and adolescent events. Science, 1970; 169:397–399.

Frisch R. E. Body fat, menarche, fi tness and fertility. Hum. Reprod., 1987; 2:521–533.

Frishman G. N., Hackett R. J., McGrath M., Metheny W. P. Evaluation of the prognosis of in vitro fertilization pregnancies with initially low serum human chorionic gonadotropin levels. Am. J. Obstet. Gynecol., 2001; 185:2392–2395.

Frobenius W. Ludwig Fraenkel: ’spiritus rector’ of the early progesterone research. Europ. J. Obstet. Gynecol. Reproduc. Biol., 1999; 83:115–119.

Frye C. A., Walf A. A. Estrogen and/or progesterone administered systemically or to the amygdala can have anxiety-, fear-, and pain-reducing effects in ovariectomized rats. Behavioral Neuroscience, 2004; 118:306–313.

Furukawa K., et al. Hormonal pregnancy tests and congenital malformation. Nature, 1967; 216:83.

Gallagher E. J. Application of likelihood ratios to clinical decision rules: defining the limits of clinical expertise. Ann. Emerg. Med., 1999; 34:664–667.

Gallaway M. S. The association between maternal use of spermicides, condoms, intra-uterine devices or progesterone and major structural birth defects. The University od Texas School of Public Health. Houston, 2008;139.

Gambrell Jr. R. D. Prevention of endometrial cancer with progestogens. Maturita, 1986;8:159–168.

Gann P. H., et al. The effects of a lowfat/high-fiber diet on sex hormone levels and menstrual cycling in premenopausal women: a 12-month randomized trial (the diet and hormone study). Cancer, 2003; 98:1870–1879.

Garcia E., et al. Use of immunocytochemistry of progesterone and estrogen receptors for endometrial dating. J. Clin. Endocrinol. Metab., 1988; 67:80–87.

Garde R. V., Saner C. N., Price T. M. Discovery of a truncated progesterone receptor (PR-M) in the mitochondria; Plenary Oral Presentation, Wyeth Presidential Award, Society for Gynecological Investigation at the 53rd Annual Meeting; Toronto, Canada. March 2006.

Gardill B. R., et al. Corticosteroid-Binding Globulin: Structure-Function Implications from Species Differences. PLoS ONE, 2012; 7 (12):e52759.

Garn S. M., LaVelle M. Reproductive histories of low weight girls and women. Am. J. Clin. Nutr., 1983; 37:862–6.

Gaskins A. J., et al. Effect of daily fiber intake on reproductive function: the BioCycle Study1–3. Am. J. Clin. Nutr., 2009; 90:1061–1069.

Gauche´-Cazalis C., et al. Endometriosis and implantation: Myths and facts. Middle East Fertility Society Journal, 2012; 17:79–81.

Gavrilova-Jordan L. P., et al. Expression of a truncated progesterone receptor isoform (PR-M) in pregnant and laboring myometrium. Reprod. Sci., 2009; 16 (3 suppl):114A.

Gavrilova-Jordan L. P., et al. Expression of a truncated progesterone receptor (PR-M) correlates with mitochondrial content in human tissues. Reprod. Sci., 2009; 16 (3 suppl):189A.

Gelle P., Schaeffer P. Apropos of the use of dydrogesterone in gynecology and obstetrics; clinical experience. Bull. Fed. Soc. Gynecol. Obstet. Lang. Fr., 1965; 17:369–370.

Gellersen B., Brosens I. A., Brosens J. J. Decidualization of the human endometrium: mechanisms, functions, and clinical perspectives. Sem. Reproduc. Med., 2007; 25:445–453.

Gellersen B., Brosens J. Cyclic AMP and progesterone receptor cross-talk in human endometrium: a decidualizing affair. J. Endocrinol., 2003; 178:357–372.

Gellersen B., Fernandes M. S., Brosens J. J. Non-genomic progesterone actions in female reproduction. Human Reproduction Update, 2009; 15:119–138.

Gemmell R. T. A comparative study of the corpus luteum. Reprod. Fertil. Dev., 1995; 7:303–312.

Genazzani A. R., et al. Progesterone, progestagens and the central nervous system. Hum. Reprod., 2000; 15 Suppl 1:14–27.

Gerhard I., et al. Doubleblind controlled trial of progesterone substitution in threatened abortion. Biol. Res. Pregnancy Perinatol.,1987; 8:26–34.

Gharabaghi P., et al. Comparing the levels of ßHCG, progesterone and estradiol between ectopic pregnancy and normal intrauterine pregnancy.Iranian Journal of Reproductive Medicine, 2007; 5 (4):187–190.

Giangrande P. H., et al. The opposing transcriptional activities of the two isoforms of the human progesterone receptor are due to differential cofactor binding. Mol. Cell. Biol.,2000; 20:3102–3115.

Gibaldi M., Boyes R. N., Feldman S. Influence of first-pass effect on availability of drugs on oral administration. J. Pharm. Sci., 1971; 60:1338–1340.

Gill J. The effect of moderate alcohol consumption on female hormone lebels and reproductive function. Alcohol & Alcoholism, 2000; 35 (5):417–423.

Gillet J. Y., et al. Induction of amenorrhea during hormone replacement therapy: optimal micronized progesterone dose. A multicenter study. Maturitas, 1994; 19:103–115.

Ginsberg K. A., Dinsay R. In: Ransom S. B., ed. Practical Strategies in Obstetrics and Gynecology. Philadelphia: W.B. Saunders; 2000:684–9.

Giudice L. C., Kao L. C. Endometriosis. Lancet, 2004; 364:1789–1799.

Giudice L. C. Genes associated with embryonic attachment and implantation and the role of progesterone. J. Reprod. Med., 1999; 44:165–171.

Giudice L. C. Implantation and endometrial function. In: Reproductive medicine Molecular, cellular and genetic fundamentals, Ed. B.C.Fauser. Lancaster: Parthenon, 2002; 439–461.

Givens C. R., et al. Elevated serum progesterone levels on the day of human chorionic gonadotropin administration do not predict outcome in assisted reproduction cycles. Fertil. Steril., 1994; 62:1011–1017.

Goktolga U., et al. Assessment of the predictive value of serum progesterone levels on early pregnancy prognosis in spontaneous twin gestations: A prospective study. Europ. J. Obstet. Gynecol. Reprod. Biol., 2008; 137:185–188.

Goldenberg R. L., et al. Epidemiology and causes of preterm birth. Lancet, 2008; 371:75–84.

Goldman A. S., Bongiovanni A. M. Induced genital anomalies. Ann. NY Acad. Sci.,1967; 142:755–767.

Goldman S., et al. Progesterone receptor expression in human decidua and fetal membranes before and after contractions: possible mechanism for functional progesterone withdrawal. Mol. Hum. Reprod., 2005; 11:269–277.

Goldstein P., et al. A meta-analysis of randomized control trials of progestational agents in pregnancy. Br. J. Obstet. Gynecol., 1989; 96:265–274.

Goldzieher J. W. Double-blind trial of a progestin in habitual abortion. JAMA, 1964; 188:651–654.

Goletiani N. V., Keith D. R., Gorsky S. J. Progesterone: Review of Safety for Clinical Studies. Experimental and Clinical Psychopharmacology, 2007; 15 (5):427–444.

Golub M. S., et al. ’Natural’ Progesterone: Information on Fetal Effects Birth Defects Research (Part B), 2006; 77:455–470.

Golub M. S., et al. Evidence on developmental and reproductive toxicity of progesterone. Reproductive and Cancer, Hazard Assessment Section, August 2004.

Gómez E., Tarín J. J., Pellicer A. Oocytes maturation in humans: the role of gonadotrophins and growth factors. Fertil. Steril., 1993; 60:40–46.

Gonda X., et al. Patterns of Mood changes throughout the reproductive cycle in healthy women without premenstrual dysphoric disorders. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 2008; 32:1782–1788.

Gonzalez-Arenas A., et al. Regulation of progesterone receptor isoforms expression by sex steroids in the rat lung. J. Steroid Biochem. Mol. Biol., 2003; 85:25–31.

Gorodeski G. I. Is progesterone a vasodilator? Menopause, 2004; 11 (3):242–243.

Gottschall J. A., Gottschall T. A. Are per-incident rape-pregnancy rates higher than per-incident consensual pregnancy rates? Human Nature, 2003; 14:1–20.

Goyeneche A. A., Caron R. W., Telleria C. M. Mifepristone inhibits ovarian cancer cell growth in vitro and in vivo. Clinical Cancer Research, 2007; 13:3370–3379.

Gracia C. R., Barnhart K. T. Diagnosing ectopic pregnancy: decision analysis comparing six strategies. Obstet. Gynecol., 2001; 97:464–470.

Graham J. D., Clarke C. L. Physiological action of progesterone in target tissues. Endocrine Reviews, 1997; 18:502–519.

Graham J. D., et al. Characterization of progesterone receptor A and B expression in human breast cancer. Cancer Research, 1995; 55:5063–5068.

Graham J. D., et al. DNA replication licensing and progenitor numbers are increased by progesterone in normal human breast. Endocrinol., 2009; 150:3318–3326.

Gray S. H., et al. Salivary Progesterone Levels Before Menarche: A Prospective Study of Adolescent Girls. J. Clin. Endocrinol. Metab., 2010; 95:3507–3511.

Graziottin A., Serafini A. Depression and the menopause: why antidepressants are not enough? Menopause Int., 2009; 15:76–81.

Greendale G. A., et al. Symptom relief and side effects of postmenopausal hormones: results from the Postmenopausal Estrogen/Progestin Interventions Trial. Obstet. Gynecol., 1998; 2 (6):982–8.

Greene R., Burrill M., Ivy A. Progesterone is androgenic. Endocrinol., 1939; 24:351–357.

Gregoire A. J., et al. Transdermal oestrogen for treatment of severe postnatal depression. Lancet, 1996; 347:930–933.

Gruber C. J., Huber J. C. Differential effects of progestins on the brain. Maturitas, 2003; 46 (Suppl 1):71–75.

Gruber C. J., Huber J. C. The role of dydrogesterone in recurrent (habitual) abortion. J. Ster. Biochem. Mol. Biol., 2005; 97:426–430.

Gruber I., Just A., Birner M., Lo¨sch A. Serum estradiol/progesterone ratio on day of embryo transfer may predict reproductive outcome following controlled ovarian hyperstimulation and in vitro fertilization. J. Exp. Clin. Assist. Reprod., 2007; 4:1.

Grumbach M., Ducharme J., Moloshok R. On the fetal masculinising action of certain oral progestins. J. Clin. Endocrinol. Metab., 1959; 19:1369–1380.

Guapo V. G., et al. Effects of sex hormonal levels and phases of the menstrual cycle in the processing of emotional faces. Psychoneuroendocrinology, 2009; 34 (7):1087–1094.

Gude N. M., et al. Growth and function of the normal human placenta. Thromb Res., 2004; 114:397–407.

Guerra J. A., López-Muñoz F., Álamo C. Progestins in Combined Contraceptives. J. Exp. Clin. Med., 2013; 5 (2):51–56.

Guo S. W. Epigenetics of endometriosis. Mol. Human. Reproduc., 2009; 15:587–607.

Gupta S., et al. Pathogenic mechanisms in endometriosis-associated infertility. Fertil. Steril., 2008; 90:247–257.

Haines C. J., Emes A. L. The relationship between follicle diameter, fertilization rate and microscopic embryo quality. Fertil. Steril., 1991; 55:205–207.

Halbreich U., Borenstein J., Pearlstein T., Kahn L. S. The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD). Psychoneuroendocrinology, 2003; 28 (Suppl 3):1–23.

Halbreich U., et al. Premenstrual changes and changes in gonadal hormones. Acta Psychiatrica Scandinavica, 1986; 74:576–586.

Hampton A. L., Salamonsen L. A. Endometrial expression of messenger ribonucleic acid encoding matrix metalloproteinases and their tissue inhibitors coincides with menstruation. J. Endocrinol., 1994; 141:R1–R3.

Haney A. F., Hughes S. F., Hughes Jr. C. L. Synthetic estrogens suppress granulose cell progesterone production in vitro. Reproductive Toxicology, 1990; 4:3–10.

Hardie E. A. Prevalence and predictors of cyclic and noncyclic affective change. Psychology of Women Quarterly, 1997; 21:299–314.

Hargrove J. T., Maxson W. S., Wentz A. C. Absorption of oral progesterone is influenced by vehicle and particle size. Am. J. Obstet. Gynecol., 1989; 161:948–951.

Harini C., et al. Progesterone administration induces preimplantation embryonic loss in mice. Fertil. Steril., 2009; 91:2137–2141.

Harlap S., Prywes R., Davies A. M. Letter: Birth defects and oestrogens and progesterones in pregnancy. Lancet, 1975; 1:682–683.

Harper C. V., et al. Encoding of progesterone stimulus intensity by intracellular [Ca2+] ([Ca2+] i) in human spermatozoa. Biochem. J., 2003; 372:407–417.

Harrison W. M., et al. Characteristics of women seeking treatment for premenstrual syndrome. Psychosomatics, 1989a; 30:405–411.

Hartmann M., Wettstein A. Ein krystallisiertes Hormon aus Corpus luteum. Helvetica Chimica Acta, 1934; 17:878–882.

Haskins A. L., Taubert S. D. Progesteron transportation in blood. JACOG, 1963; 21 (4):395–399.

Hawgood B. J. Karl Heinrich Slotta (1895–1987) biochemist: snakes, pregnancy and coffee. Toxicon, 2001; 39:1277–1282.

Hayashi A., et al. Dienogest increases the progesterone receptor isoform B/A ratio in patients with ovarian endometriosis. Journal of Ovarian Research, 2012; 5:31–39

Hayles A. B., Nolan R. B. Female pseudohermaphroditism; report of case in an infant born of a mother receiving methyltestosterone during pregnancy. Mayo Clin. Proc., 1957; 32:41–44.

Heikinheimo O., et al. Estrogen and progesterone receptor mRNA are expressed in distinct pattern in male primate reproductive organs. J. Assist. Reprod. Genet., 1995; 12:198–204.

Heinonen O. P., et al. Cardiovascular birth defects and antenatal exposure to female sex hormones. N. Engl. J. Med., 1977; 296:67–70.

Henderson J. Ernest Starling and ’Hormones’: an historical commentary. Endocrinol., 2005; 184:5–10.

Hendricks M. S., Chin H., Loh S. F. Treatment outcome of women with a single ovary undergoing in vitro fertilisation cycles/ Singapore Med. J., 2010; 51 (9):698.

Hendrickx A. G., et al. Embryotoxicity of sex steroidal hormone combinations in nonhuman primates: L-Norethisterone acetate + ethinylestradiol and progesterone + estradiol benzoate (Macaca mulatta, Macaca fascicularis, and Papio cynocephalus). Teratology, 1987; 35:119–127.

Henmi H., et al. Effects of ascorbic acid supplementation on serum progesterone levels in patients with a luteal phase defect. Fertil. Steril., 2003; 80 (2):459–461.

Henriet P., Chevronnay H. P. G., Marbaix E. The endocrine and paracrine control of menstruation. Molecular and Cellular Endocrinology, 2012; 358:197–207.

Hensleigh P. A., Fainstat T. Corpus luteum dysfunction: serum progesterone levels in diagnosis and assessment of therapy for recurrent and threatened abortion. Fertil. Steril., 1979; 32:715–719.

Hermann A. C., et al. Over-the-counter progesterone cream produces significant drug exposure compared to a food and drug administration-approved oral progesterone product. J. Clin. Pharmacol., 2005; 45:614–619.

Hermann W. L., Schlindler A. M. Wyss R., Bischoff P. Effects of anti-progesterone RU 486 in early pregnancy and during the menstrual cycle. In: Beaulieu E. E., Siegel S., editors. The Antiprogestin Steroid RU 486 and Human Fertility Control. New York: Plenum; 1985; 259–262.

Hertig A. T. Allen and Doisy’s ’An Ovarian Hormone’. JAMA, 1983; 250 (19):2684–2688.

Herzog A. G. Hormonal Therapies: Progesterone Neurotherapeutics: The Journal of the American Society for Experimental NeuroTherapeutics, 2009; 6:383–391.

Herzog A. G. Progesterone therapy in complex partial and secondary generalized seizures. Neurology, 1995; 45:1660–1662.

Herzog A. G. Progesterone therapy in women with epilepsy: a 3-year follow-up. Neurology, 1999; 52:1917–1918.

Hewedi I. H., et al. Diagnostic value of progesterone receptor and p53 expression in uterine smooth muscle tumors. Diagnostic Pathology, 2012; 7:1.

Hibbert M. L., et al. Midcycle administration of a progesterone synthesis inhibitor prevents ovulation in primates. Proceedings of the National Academy of Sciences of the United States of America, 1996; 93:1897–1901.

Hickey M., et al. Long-term progestin-only contraceptives result in reduced endometrial blood flow and oxidative stress. J. Clin. Endocrinol. Metab., 2006; 91:3633–3638.

Hicks C. W., Rome E. S. Menstrual manipulation: Options for suppressing the cycle. Cleveland Clinical Journal of Medicine, 2010; 77 (7):445–453.

Hidalgo M., et al. Bleeding patterns and clinical performance of the levonorgestrel-releasing intrauterine system (Mirena) up to two years. Contraception. 2002; 65:129–132.

Hildebrand M. S., et al. Genetic male infertility and mutation of CATSPER ion channels. Eur. J. Hum. Genet., 2010; 18:1178–1184.

Hileman S. M., Pierroz D. D., Flier J. S. Leptin, Nutrition, and Reproduction: Timing is Everything. J. Clin. Endocrinol. Metab., 2000; 85:804–807.

Hill M., et al. Reduced Progesterone Metabolites in Human Late Pregnancy. Physiol. Res., 2011; 60:225–241.

Hill P., et al. Diet and follicular development. Am. J. Clin. Nutr., 1984; 39:771–777.

Hillard P. Menstruation in adolescents, what’s normal, what’s not. Ann. N. Y. Acad. Sci., 2008; 1135:29–35.

Hillier S. G. Sex steroid metabolism and follicular development in the ovary. Oxf. Rev. Reprod. Biol., 1985; 7:168–222.

Hillman D. Fetal masculinization with maternal progesterone therapy. Can. M. A. J., 1959; 80:200–201.

Hodges Y. K., et al. Variant estrogen and progesterone receptor messages in human vascular smooth muscle. Circulation, 1999; 99 (20):2688–2693.

Hofmann G. E., et al. Evaluation of the reproductive performance of womenwith elevated day 10 progesterone levels during ovarian reserve screening. Fertil. Steril., 1995; 63:979–983.

Holmes P. V., et al. Effects of high and low preovulatory concentrations of progesterone on ovulation from the isolated perfused rabbit ovary. J. Reprod. Fertil., 1985; 75,393–399.

Holtorf K. The bioidentical hormone debate: are bioidentical hormones (estradiol, estriol, and progesterone) safer or more efficacious than commonly used synthetic versions in hormone replacement therapy? Postgrad. Med., 2009; 121:73–85.

Homan G., et al. Human chorionic gonadotropin as a predictor of outcome in assisted reproductive technology pregnancies. Fertil. Steril., 2000; 73:270–274.

Hopp T. A., et al. Breast cancer patients with progesterone receptor PR-A-rich tumors have poorer disease-free survival rates. Clinical Cancer Research, 2004; 10:2751–2760.

Horta J. L., et al. Direct evidence of luteal insufficiency in women with habitual abortion. Obstet. Gynecol., 1977; 49:705–708.

Hsieh C. C., et al. Age at menarche, age at menopause, height and obesity as risk factors for breast cancer: associations and interactions in an international casecontrol study. Int. J. Cancer, 1990; 46:796–800.

Huber J. C., Ott J. The dialectic role of progesterone. Maturitas, 2009; 62:326–329.

Hudson R., Pharriss B. B., Tillson S. A. Preclinical evaluation of intrauterine progesterone as a contraceptive agent. III. Embryology and toxicology. Contraception, 1978; 17:489–497.

Hughes G. C. Progesterone and autoimmune disease. Autoimmunity Reviews, 2012; 11:A502–A514.

Hugues J. N. Impact of ’LH activity’ supplementation on serum progesterone levels during controlled ovarian stimulation: a systematic review. Human Reproduction, 2012; 27 (1):232–243.

Hull E. M. Effects of neonatal exposure to progesterone in sexual behavior of male and female rats. Physiol. Behav., 1981; 26:401–405.

IARC (International Agency for Research on Cancer). Overall evaluation of carcinogenicity: an updating of IARC monographs volumes 1–42: Progestins; combined oral contraceptives. Suppl. 7. Albany, NY: WHO Publications Centre USA, 1987.

Iftikhar S., et al. Use of bioidentical hormones for menopausal concerns: cross sectional survey in an academic menopause center. J. Women s Health, 2011; 20:559–565.

Igarashi M. Augmentive effect of ascorbic acid upon induction of human ovulation in clomiphene-ineffective anovulatory women. Int. J. Fertil., 1977; 22:168–173.

Ikka T., Kawashima K. Studies on the virilizing activities of synthetic hormones in female rat fetuses: IV. Synergic effect of estrogens on the vrilizing activity of gestagens. Congen Anomalies, 2001; 41:269.

IngamellsIain S., Cameron I. T. Disorders of ovulation. Women’s Health Medicine, 2006; 3:3:109–112.

Inoue T., et al. Spatial and topological distribution of progesterone receptor A and B isoforms during human development. Mol. Cell. Endocrinol., 2001; 182:83–89.

Insler V. Corpus luteum defects. Curr. Opin. Obstet. Gynecol., 1992; 4:203–211.

Isaacs J. D., Whitworth N. S., Cowan B. D. Relative operating characteristic analysis in reproductive medicine: comparison of progesterone and human chorionic gonadotropin doubling time as predictors of early gestational normalcy. Fertil. Steril., 1994; 62:452–445.

Ishikawa H., et al. Progesterone Is Essential for Maintenance and Growth of Uterine Leiomyoma. Endocrinol., 2010; 151 (6):2433–2442.

Israel R., et al. Single luteal phase serum progesterone assay as an indicator of ovulation. Am. J. Obstet. Gynecol., 1972; 112:1043–1046.

Jabbour H. N., Critchley H. O. Potential roles of decidual prolactin in early pregnancy. Reproduction, 2001; 121:197–205.

Jabbour H. N., et al. Endocrine Regulation of Menstruation. Critchley Endocrine Reviews, 2006; 27 (1):17–46.

Jacob A., et al. Human sperm non-nuclear progesterone receptor expression is a novel marker for fertilization outcome. Mol. Hum. Reprod., 1998; 4:533–542.

Jacobsen B. M., Horwitz K. B. Progesterone receptors, their isoforms and progesterone regulated transcription. Molecular and Cellular Endocrinology, 2012; 357:18–29.

Jaiswal B. S., Eisenbach M. Capacitation. In: Hardy D. M., ed. Fertilization. San Diego: Academic Press, 2002; 57–117.

Jamain M. & Grenet C. Utilization of 6-dehydro-retroprogesterone in obstetrics: indications; results. Bull. Fed. Soc. Gynecol. Obstet. Lang. Fr., 1969; 21:26–31.

James A., Matchar D. B., Myers E. R. Testing for von Willebrand disease in women with menorrhagia: a systematic review. Obstet. Gynecol., 2004; 104:381–388.

James W. J. Women’s hormone concentrations and the increasing rates of ectopic pregnancy. Hum. Reprod., 1996; 11:233–235.

Janeczko A., Skoczowski A. Mammalian sex hormones in plants. Folia Histochem. Cytobiol., 2005; 43 (2):71–79.

Jemal A., et al.Global cancer statistics. CA Cancer J. Clin., 2011; 61:69–90.

Jenkins R. L., et al. Androstenedione and progesterone in the sediment of a river receiving paper mill effluent. Toxicol. Sci., 2003; 73:53–59.

Jensen M. B., Publicover S. J. Progesterone and CatSper dependency. International Journal of Andrology, 2012; 35:631–632.

Jerry D. J. Roles for estrogen and progesterone in breast cancer prevention. Breast Cancer Res., 2007; 9:102.

Jin M., et al. Most fertilizing mouse spermatozoa begin their acrosome reaction before contact with the zona pellucida during in vitro fertilization. Proc. Natl. Acad. Sci. USA, 2011; 108:4892–4896.

Joachim R., et al. The progesterone derivative dydrogesterone abrogates murine stress-triggered abortion by inducing a Th2 biased local immune response. Steroids, 2003; 68:931–940.

Johnson M. H., Everitt B. J. Adult ovarian function. In Essential Reproduction. Oxford: Blackwell Science, 2000; 5:74–75.

Johnson W. S., Gravestock M. B., McCarry B. E. Acetylenic bond participation in biogenic like olefinic cyclizations. II. Synthesis of dl-Progesterone. JACS, 1971; 4332–4334.

Jones H. W. Jr., Wilkins L. The genital anomaly associated with prenatal exposure to progestogens. Fertil. Steril., 1960; 11:148–156.

Jones L. A., Bern H. A. Cervicovaginal and mammary gland abnormalities in BALB/cCrgl mice treated neonatally with progesterone and estrogen, alone or in combination. Cancer Res., 1979; 39:2560–2567.

Jones L. A., Bern H. A. Long-term effects of neonatal treatment with progesterone, alone and in combination with estrogen, on the mammary gland and reproductive tract of female BALB/cfC3H mice. Cancer Res., 1977; 37:67–75.

Jones L. A., et al. Prevention by progesterone of cervicovaginal lesions in neonatally estrogenized BALB/c mice. Cancer Lett., 1984; 23:123–128.

Jordan V. C. Long-term adjuvant tamoxifen therapy for breast cancer. Breast Cancer Research and Treatment, 1990; 15:125–136.

Joshi P. A., et al. Progesterone induces adult mammary stem cell expansion. Nature, 2010; 465:803–807.

Jukic A. M., et al. Lifestyle and reproductive factors associated with follicular phase length. J. Women s Health (Larchmt), 2007; 16:1340–1347.

Jukica A. M. Z., et al. Effects of early pregnancy loss on hormone levels in the subsequent menstrual cycle. Gynecol. Endocrinol., 2010; 26 (12):897–901.

Junkmann K., Neumann F. The mechanism of action of progestational hormones in the anti-masculine effect on fetal rats. Acta Endocrinol. (Copenh), 1964; 45 (Suppl 90):139–153.

Jurkowski J. E., et al. Ovarian hormonal responses to exercise. J. Appl. Physiol.,1978;44:109–114.

Kadohama N., et al. Inhibitory effects of some steroidal 6-methylene derivatives on 5-alpha-reductase activity in human and rat prostate. J. Steroid. Biochem.,1983; 18:551–558.

Kalantaridou S. N., et al. Stress and the female reproductive system. J. Reprod. Immunol., 2004; 62:61–68.

Kalinka J., Szekeres-Bartho J. The impact of dydrogesterone supplementation on hormonal profile and progesterone-induced blocking factor concentrations in women with threatened abortion. Am. J. Reprod. Immunol., 2005; 53:166–171.

Kallen B., et al. A joint international study on the epidemiology of hypospadias. Acta Paediatr. Scand. Suppl., 1986; 324:1–52.

Kallen B., et al. Hormone therapy during pregnancy and isolated hypospadias: an international case-control study. Int. J. Risk. Safe. Med., 1992; 3:183–198.

Kallen B., et al. Oral contraceptives in the etiology of isolated hypospadias. Contraception, 1991b; 44:173–182.

Kallen B., et al. Parental fertility and infant hypospadias: an international case-control study. Teratology, 1991a; 44:629–634.

Kallen B., Winberg J. An epidemiological study of hypospadias in Sweden. Acta Paediatr. Scand. Suppl., 1982; 293:1–21.

Kallen B. Case control study of hypospadias, based on registry information. Teratology, 1988; 38:45–50.

Kanaley J. A., et al. Cortisol levels during prolonged exercise the influence of menstrual phase and menstrual status. Int. J. Sports. Med., 1992; 13:332–336.

Kaorea S. N., et al. Novel actions of progesterone: what we know today and what will be the scenario in the future? Royal Pharmaceutical Society Journal of Pharmacy and Pharmacology, 2012; 64:1040–1062.

Kaplowitz P. B., et al. Earlier onset of puberty in girls: relation to increased body mass index and race. Pediatrics, 2001; 108:347–353.

Karas R. H., et al. A complex role for the progesterone receptor in the response to vascular injury. J. Clin. Invest., 2001; 108:611–618.

Karita M., et al. Does advanced-stage endometriosis affect the gene expression of estrogen and progesterone receptors in granulosa cells? Fertil. Steril., 2011; 95:889–894.

Kasahara M., et al. Studies on the virilizing activities of synthetic hormones in female rat fetuses: III. Structure activity of various hormones. Cong. Anomalies, 2001; 41:268–269.

Kashani H. H., et al. Pharmacological properties of medicinal herbs by focus on secondary metabolites. Life Science Journal, 2012; 9 (1):509–520.

Katz Z., et al. Teratogenicity of progestogens given during the first trimester of pregnancy. Obstet. Gynecol., 1985; 65:775–780.

Kawashima K., et al. Virilizing activities of various steroids in female rat fetuses. Endocrinol. Jpn., 1977; 24:77–81.

Kawashima K. Studies on the virilizing activities of synthetic hormones in female rat fetuses: III. Structure activity of various hormones. Cong. Anomalies, 2001; 41:268–269.

Kawashima S., et al. Histometric study of the pituitary in mice treated neonatally with steroids and the relationship between prolactin cells and mammary tumorigenesis. Endocrinol. Jpn., 1978; 25:341–348.

Keating E., et al. Progesterone Inhibits Folic Acid Transport in Human Trophoblasts. J. Membrane Biol., 2007; 216:143–152.

Kelemen K., et al. A progesterone-induced protein increases the synthesis of asymmetric antibodies. Cell. Immunol., 1996; 167:129–134.

Kelemen K., Paldi A., Tinneberg H., et al. Early recognition of pregnancy by the maternal immune system. Am. J. Reprod. Immunol., 1998; 39:351–355.

Kenyon A. P., Peebles D. Myth: Tocolysis for prevention of preterm birth has a major role in modern obstetrics. Seminars in Fetal & Neonatal Medicine, 2011; 16:242–246.

Khan A. M., et al. Acute eosinophilic pneumonia with intramuscular progesterone after in vitro fertilization. Fertil. Steril., 2008; 90:1200.e3–6.

Kiguchi M., et al. Studies on virilizing activities of synthetic hormones in female rat fetuses: II. Progesterone and derivatives. J. Toxicol. Sci., 2001; 26:262.

Kilic F., et al. Caged progesterone: a new tool for studying rapid nongenomic actions of progesterone. J. Am. Chem. Soc., 2009; 131:4027–4030.

Kim J. J., Kurita T., Bulun S. E. Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer. Endocr. Rev., 2013; 34 (1):130–162.

King A., et al. Functions of human decidual NK cells. Am. J. Reprod. Immunol., 1996; 35:258–260.

King A., et al. Human uterine lymphocytes. Hum. Reprod. Update, 1998; 4:480–485.

King A., Gardner L., Loke Y. W. Evaluation of oestrogen and progesterone receptor expression in uterine mucosal lymphocytes. Hum. Reprod., 1996; 11:1079–1082.

King A. Uterine leukocytes and decidualization. Hum. Reprod. Update, 2000; 6:28–36.

King A. E., Critchley H. O. Oestrogen and progesterone regulation of inflammatory processes in the human endometrium. J. Steroid. Biochem. Mol. Biol., 2010; 120 (2–3):116–126.

Kinnunen T. I., et al. Pregnancy weight gain and breast cancer risk. BMC Women s Health 2004; 4; 7:1–10.

Klebanov P. K., Jemmot J. B. Effects of expectations and bodily sensations on self-reports of premenstrual symptoms. Psychology of Women Quarterly, 1992; 16:289–310.

Klijn J. G., Setyono-Han B., Foekens J. A. Progesterone antagonists and progesterone receptor modulators in the treatment of breast cancer. Steroids, 2000; 65:825–830.

Kline L. W., Karpinski E. Progesterone inhibits gallbladder motility through multiple signaling pathways. Steroids, 2005; 70 (9):673–679.

Knackstedt M. K., et al. Th1 cytokines and the prothrombinase fgl2 in stress-triggered and inflammatory abortion. Am. J. Reprod. Immunol., 2003; 49:210–220.

Knight C. Menstruation as medicine. Soc. Sci. Med., 1985; 21 (6):671–683.

Kocer A., et al. Germ cell sex determination in mammals. Mol. Human. Reprod., 2009; 15 (4):205–213.

Kol S., Humaidan P., Itskovitz-Eldor J. GnRH agonist ovulation trigger and hCG-based, progesterone-free luteal support: a proof of concept study. Human Reproduction, 2011; 26 (10):2874–2877.

Kolibianakis E. M., Devroey P. The luteal phase after ovarian stimulation. Reprod. Biomed. Online, 2002; 5:26–35.

Kolibianakis E. M., et al. Abnormal endometrial development occurs during the luteal phase of non supplemented donor cycles treated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonists. Fertil. Steril., 2003; 80:464–466.

Kolpin D. W., et al. Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999–2000: a national reconnaissance. Environ Sci. Technol., 2002; 36:1202–1211.

Komatsu T., et al. Expression of class I human leukocyte antigen (HLA) and β2-microglobulin is associated with decidualization of human endometrial stromal cells. Hum. Reprod., 1998; 13:2246–2251.

Kondo I., Suganuma N. Embryo quality in failed in vitro fertilization patients. Hum. Reprod., 1994; 4:80–84.

Konno T., et al. Subfertility Linked to Combined Luteal Insufficiency and Uterine Progesterone Resistance. Endocrinol., 2010; 151:4537–4550.

Korownyk C., Allan M., McCormack J. Bioidentical hormone micronized progesterone. Can. Fam. Physic, 2012; 58:755.

Kousta E., et al. Sex determination and disorders of sex development according to the revised nomenclature and classification in 46,XX individuals. Hormones (Athens), 2010; 9 (3):218–232.

Kramer M. M., Harman M. T., Brill A. K. Disturbances of reproduction and ovarian changes in the guinea-pig in relation to vitamin C deficiency. Am. J. Physiol., 1933; 106:611–622.

Krassas G. E. Thyroid Disease and Female Reproduction. Fertil. Steril., 2000; 74:1063–1070.

Krausz C., et al. Two functional assays of sperm responsiveness to progesterone and their predictive values in in-vitro fertilization. Hum. Reprod., 1996; 11:1661–1667.

Krikun G., Schatz F., Lockwood C. J. Endometrial angiogenesis: from physiology to pathology. Ann. N. Y. Acad. Sci., 2004; 1034:27–35.

Kubasick N. K., Hallawer G. D., Brodows R. G. Evaluation of a direct solid phase radioimmunoassay for progesterone. Clin. Chem., 1984; 30:284–286.

Kugaya A., et al. Increase in prefrontal cortex serotonin 2A receptors following estrogen treatment in postmenopausal women. Am. J. Psychiatry, 2003; 160:1522–1524.

Kuhl H. Pharmacology of estrogens and progestogens: influence of different routes of administration. Climacteric, 2005; 8 (suppl 1):3–63.

Kunz G., et al. Adenomyosis as a disorder of the early and late human reproductive period. Reproductive Biomedicine Online, 2007; 15:681–685.

Kunz G., et al. Adenomyosis in endometriosis — prevalence and impact on fertility. Evidence from magnetic resonance imaging. Human Reproduc., 2005; 20:2309–2316.

Kupperman H. Progesterone and related steroids in the management of abortion. In: Barnes A., editor. Progesterone. Augusta, MI: Brook Lodge Press, 1961;105–117.

Kurita T., et al. Stromal progesterone receptors mediate the inhibitory effects of progesterone on estrogen-induced uterine epithelial cell deoxyribonucleic acid synthesis. Endocrinology, 1998; 139:4708–4713.

Kurokawa J., Furukawa T. Non-genomic Action of Sex Steroid Hormones and Cardiac Repolarization. Biol. Pharm. Bull., 2013; 36 (1):8–12.

Kwak-Kim J. Y., et al. Increased T helper 1 cytokine responses by circulating T cells are present in women with recurrent pregnancy losses and in infertile women with multiple implantation failures after IVF. Hum. Reprod., 2003; 18:767–773.

Kyrou D., et al. Does cessation of progesterone supplementation during early pregnancy in patients treated with recFSH/GnRH antagonist affect ongoing pregnancy rates? A randomized controlled trial. Human Reproduction, 2011; 26 (5):1020–1024.

Labarta E., et al. Endometrial receptivity is affected in women with high circulating progesterone levels at the end of the follicular phase: a functional genomics analysis. Human Reproduction, 2011; 26 (7):1813–1825.

Laflamme N., et al. Expression and neuropeptidergic characterization of estrogen receptors (ERalpha and ERbeta) throughout the rat brain: anatomical evidence of distinct roles of each subtype. J. Neurobiol., 1998; 36:357–378.

Lagiou P., et al. Diet during pregnancy and levels of maternal pregnancy hormones in relation to the risk of breast cancer in the offspring. Eur. J. Cancer Prev., 2006; 15 (1):20–26.

Lainea M. A., Ojanotko A. O. Progesterone metabolism in human saliva in vitro. Journal of Steroid Biochemistry and Molecular Biology, 1999; 70:109–113.

Laitinen J., Power C., Järvelin M. R. Family social class, maternal body mass index, childhood body mass index, and age at menarche as predictors of adult obesity. Am. J. Clin. Nutr., 2001; 74:287–94.

Lambert J. J., et al. Neurosteroid modulation of GABAA receptors. Prog. Neurobiol., 2003; 71:67–80.

Lanari C., et al. Antiprogestins in breast cancer treatment: are we ready? Endocrine-Related Cancer, 2012; 19:R35–R50.

Landau R. L., Lugibihl K. Inhibition of the sodium retaining influence of aldosterone by progesterone. J. Clin. Endocrinol. Metab., 1958; 18:1237–1245.

Lange C., Yee D. Progesterone and breast cancer. Women’s Health, 2008; 4 (2):151.

Lange C. A., et al. Progesterone receptor action: translating studies in breast cancer models to clinical insights. Advances in Experimental Medicine and Biology, 2008; 630:94–111.

Larsen B., Hwang J. Progesterone Interactions with the Cervix: Translational Implications for Termand Preterm Birth. Hindawi Publishing Corporation. Infectious Diseases in Obstetrics and Gynecology, 2011; Article ID 353297:13.

Lassek W. D., Gaulin S. J. Brief communication: menarche is related to fat distribution. Am. J. Phys. Anthropol., 2007; 133:1147–51.

Lavoie J. M., et al. Menstrual cycle phase dissociation of blood glucose homeostasis during exercise. J. Appl. Physiol., 1987; 62:1084–1089.

Laycock J. F., Wise P. H. Essential endocrinology. Oxford, UK: Oxford University press, 1996.

Le Vine L. Habitual abortion: a controlled clinical study of progestational therapy. West J. Surg., 1964; 72:30–36.

Leather A. T., et al. The prevention of bone loss in young women treated with GnRH analogues with ’add-back’ estrogen therapy. Obstet. Gynecol., 1993; 81:104–107.

Leather A. T., et al. The treatment of severe premenstrual syndrome with goserelin with and without ’add-back’ estrogen therapy: a placebo-controlled study. Gynecol. Endocrinol., 1999; 13:48–55.

Ledee-Bataille N., et al. A new role for natural killer cells, interleukin (IL) -12, and IL-18 in repeated implantation failures after in vitro fertilization. Fertil. Steril., 2004; 81:59–65.

Lee J. Natural Progesterone: the multiple roles of a remarkable hormone. Sebastopol, CA: BLL Publishing, 1999.

Lee S. J., et al. The effect of age on the cyclical patterns of plasma LH, FSH, oestradiol and progesterone in women with regular menstrual cycles. Hum. Reprod., 1988; 3:851–855.

Lei K., et al. Uterine Stretch and Progesterone Action. J. Clin. Endocrinol. Metab., 2011; 96:E1013–E1024.

Lenković M., et al. Effect of Progesterone and Pregnancy on the Development of Varicose Veins. Acta Dermatovenerol Croat, 2009; 17 (4):263–267.

Lenton E. A., Landgren B. M., Sexton L. Normal variation in the length of the luteal phase of the menstrual cycle: identification of the short luteal phase. Br. J. Obstet. Gynecol., 1984; 91:685–689.

Lerner L. J., et al. Comparison of the acetophenone derivative 16alpha,17alpha — dihydroxyprogesterone with other progestational steroids for masculinisation of the rat fetus. Endocrinology, 1962; 71:448–451.

Lesny P., et al. Uterine junctional zone contractions during assisted reproduction cycles. Hum. Reprod. Update, 1998; 4:440–445.

Lessey B. A., et al. Immunohistochemical analysis of human uterine estrogen and progesterone receptors throughout the menstrual cycle. J. Clin. Endocrinol. Metab., 1988; 67:334–340.

Lessey B. A. Endometrial responsiveness to steroid hormones: a moving target. J. Soc. Gynecol. Investig., 2004; 11:61–62.

Lethaby A., et al. Hormone replacement therapy for cognitive function in postmenopausal women. Cochrane Database Syst. Rev., 2008; (1):CD003122.

Letters to the editors. Menopause: The Journal of The North American Menopause Society, 2003; 10 (4):373–381.

Levine H., Watson N. Comparison of the pharmacokinetics of Crinone 8 % administered vaginally versus prometrium administered orally in postmenopausal women. Fertil. Steril., 2000;73:516–521.

Levine J. E., et al. Progesterone receptors as neuroendocrine integrators. Front Neuroendocrinol, 2001; 22:69–106.

Levy C., et al. Estradiol and progesterone receptors in human endometrium: normal and abnormal menstrual cycles and early pregnancy. Am. J. Obstet. Gynecol., 1980; 136:646–651.

Levy E. P., Cohen A., Fraser F. C. Hormone treatment during pregnancy and congenital heart defects. Lancet, 1973; 1:611.

Lewis J. G., et al. Caution on the use of saliva measurements to monitor absorption of progesterone from transdermal creams in postmenopausal women. Maturitas, 2002; 41 (1):1–6.

Li Q., et al. The antiproliferative action of progesterone in uterine epithelium is mediated by Hand2. Science, 2011; 331:912–916.

Li T., Cooke I. Chronological and histological dating of the endometrial biopsy. Obstet. Gynecol., 1989; 1:266–272.

Li T. C. Guidelines for practitioners. Recurrent miscarriage: principles of management. Hum. Reprod., 1998; 13:478–482.

Li X., O’Malley B. W. Unfolding the action of progesterone receptors. J. Biol. Chem., 2003; 278:39261–39264.

Lianne G. The end of menstruation. Maclean’s, 2005; 118:50:41.

Lin Y. S., Liu C. H. Prediction of early pregnancy outcomes. Intern. J. Gynecol. Obstet., 1995; 51:33–38.

Lindenfeld E. A., Langer R. D. Bleeding patterns of the hormone replacement therapies in the postmenopausal estrogen and progestin interventions trial. Obstet. Gynecol., 2002; 100 (5 Pt 1):853–63.

Lishko P. V., Botchkina I. L., Kirichok Y. Progesterone activates the principal Ca2+ channel of human sperm. Nature, 2011; 471:387–391.

Lissoa B. P., Sauer H. D. Progesterone metabolism in the human myometrium. J. Sreroid. Biochem., 1975; 6:1137–1144.

Little B., et al. In vivo aspects of progesterone distribution and metabolism. Am. J. Obstet. Gynecol., 1975; 123:527–534.

Liu D. T. Y., Jeavons B., Preston C., Pearson D. A prospective study of spontaneous miscarriage in ultrasonically normal pregnancies and relevance to chorionic villus sampling. Prenat. Diagn., 2005;b 7:22–37.

Liu X. R., et al. The optimal duration of progesterone supplementation in pregnant women after IVF/ICSI: a meta-analysis. Reprod. Biol. Endocrinol., 2012; 10:107.

Lobley A., et al. Identification of human and mouse CatSper3 and CatSper4 genes: characterisation of a common interaction domain and evidence for expression in testis. Reprod. Biol. Endocrinol., 2003; 1: 53.

Lockwood C. J., et al. Progestational regulation of human endometrial stromal cell tissue factor expression during decidualization. J. Clin. Endocrinol. Metab., 1993; 76:231–236.

Lockwood C. J., et al. Progestin and thrombin regulate tissue factor expression in human term decidual cells. J. Clin. Endocrinol. Metab., 2009; 94:2164–2170.

Lockwood C. J. Mechanisms of normal and abnormal endometrial bleeding. Menopause, 2011; 18 (4):408–411.

Lodde V., Peluso J. J. A Novel Role for Progesterone and Progesterone Receptor Membrane Component 1 inRegulating Spindle Microtubule Stability During Rat and Human Ovarian Cell Mitosis. Biology of Reproduction, 2011; 84:715–722.

Loeb L. Mechanism of sexual cycle with special reference to corpus luteum. Amer. J. Anat., 1923; 32:305.

Lof M., et al. Dietary fat intake and gestational weight gain in relation to estradiol and progesterone plasma levels during pregnancy: a longitudinal study in Swedish women. BMC Women’s Health, 2009; 9:10.

Logue C. M., Moos R. H. Perimenstrual symptoms: prevalence and risk factors. Psychosomatic Medicine, 1986; 48:388–414.

Loke Y. W., King A. Human implantation. Cambridge, UK: Cambridge University Press, 1995.

Lonard D. M., O’Malley B. W. The expanding cosmos of nuclear receptor coactivators. Cell., 2006; 125:411–414.

London S., et al. Alcohol and other dietary factors in relation to serum hormone concentrations in women at climacteric. Am. J. Clin. Nutr., 1991; 53:166–171.

Loutradis D., et al. Preovulatory effects of the progesterone antagonist mifepristone (RU486) in mice. Hum. Reprod., 1991; 6:1238–1240.

Lowry O. H., et al. Protein measurements with the folin phenol reagent. J. Biol. Chem., 1951; 193:265–275.

Lozeau A. M., Potter B. Diagnosis and Management of Ectopic Pregnancy. Am. Fam. Phys., 2005; 72 (9):1707–1714.

Luck M. R., Jeyaseelan I., Scholes R. A. Ascorbic acid and fertility. Biol. Reprod., 1995; 52:262–266.

Luconi M., et al. Identification and characterization of functional nongenomic progesterone receptors on human sperm membrane. J. Clin. Endocrinol. Metab., 1998; 83:877–885.

Ludwig M., Diedrich K. Evaluation of an optimal luteal phase support protocol in IVF. Acta Obstet. Gynecol. Scand., 2001; 80:452–466.

Lydon J. P., Edwards D. P. Finally! A model for progesterone receptor action in normal human breast. Endocrinol, 2009; 150:2988–2990.

Lydon J. P., et al. Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Development, 1995; 9:2266–2278.

Mackenzie R., et al. Progesterone for the prevention of preterm birth among women at increased risk: a systematic review and meta-analysis of randomized controlled trials. Am. J. Obstet. Gynecol., 2006; 194:1234–1242.

MacLennan A., Lester S., Moore V. Oral oestrogen replacement therapy versus placebo for hot flushes. Cochrane Database Syst. Rev., 2001; CD002978.

Macnab A. J., Zouves C. Hypospadias after assisted reproduction incorporating in vitro fertilization and gamete intrafallopian transfer. Fertil. Steril., 1991; 56:918–922.

Maddocks S., Hahn P., Moller F., Reid R. L. A double-blind placebo-controlled trial of progesterone vaginal suppositories in the treatment of premenstrual syndrome. Am. J. Obstet. Gynecol., 1986; 154:573–581.

Mahesh V. B., Brann D. W., Hendry L. B. Diverse modes of action of progesterone and its metabolites. J. Steroid. Biochem. Mol. Biol., 1996; 56:209–219.

Mahesh V. B. Hirsutism, virilism, polycystic ovarian disease, and the steroid gonadotropin-feedback system: a career retrospective. Am. J. Physiol. Endocrinol. Metab., 2012; 302: E4–E18.

Makhseed M., et al. Pro-inflammatory maternal cytokine profile in preterm delivery. Am. J. Reprod. Immunol., 2003; 49:308–318.

Makhseed M., et al. Th1 and Th2 cytokine profiles in recurrent aborters with successful pregnancy and with subsequent abortions. Hum. Reprod., 2001; 16:2219–2226.

Malan Borel I., et al. IgG asymmetric molecules with antipaternal activity isolated from sera and placenta of pregnant human. J. Reprod. Immunol., 1991; 20:129–140.

Malcolm C. E., Cumming D. C. Does anovulation exist in eumenorrheic women? Obstet. Gynecol., 2003; 102:317–318.

Mangal R. K., et al. Differential Expression of Uterine Progesterone Receptor Forms A and B during the Menstrual Cycle. J. Steroid. Biochem. Molec. Biol., 1997; 63:4–6:195–202.

Manson J. M., Carr M. C. Molecular epidemiology of hypospadias: review of genetic and environmental risk factors. Birth Defects Res. Part A. Clin. Mol. Teratol., 2003; 67:825–836.

Manuck T. A., et al. Absence of Mitochondrial Progesterone Receptor Polymorphisms in Women With Spontaneous Preterm Birth. Reprod. Sci., 2010 October; 17 (10):913–916.

Manyonda I. T. The immunology of recurrent spontaneous miscarriage. In: The Immunology of Human Reproduction. 1st edn. London: Taylor & Francis, 2006; 59–77.

Marinari K. T., Leshner A. I., Doyle M. P. Menstrual cycle status and adrenocortical reactivity to psychological stress. Psychoneuroendocrinology, 1976; 1:213–218.

Marks L. V. Sexual chemistry: a history of the contraceptive pill. New Haven, CT: Yale University Press, 2001.

Marshall and Runciman: On the Ovarian Factor Concerned in the Recurrence of the Oestrous Cycle. J. Physiol., 1914; 49:17.

Marshall G. J. A. Weird Animal Genomes and the Evolution of Vertebrate Sex and Sex Chromosomes. Annu. Rev. Genet., 2008; 42:565–586.

Martin J. A., et al. Centers for Disease Control and Prevention National Center for Health Statistics. National Vital Statistics System births: final data for 2005. Natl. Vital. Stat. Rep., 2007; 56:1–103.

Martin V. T., Behbehani M. Ovarian Hormones and Migraine Headache: Understanding Mechanisms and Pathogenesis — Part 2. Headache, 2006; 46 (3):365–386.

Martin V. T., Behbehani M. Ovarian Hormones and Migraine Headache: Understanding Mechanisms and Pathogenesis — Part 1. Headache, 2006; 46 (1):3–23.

Martinez F., et al. Serum progesterone concentrations on the day of HCG administration cannot predict pregnancy in assisted reproduction cycles. Reprod. Biomed. Online, 2004; 8:183–190.

Martini L., Magnaghi V., Melcangi R. C. Actions of progesterone and its 5alpha-reduced metabolites on the major proteins of the myelin of the peripheral nervous system. Steroids, 2003; 68:825–829.

Maskarinec G., et al. Alcohol and dietary fibre intakes affect circulating sex hormones among premenopausal women. Public Health Nutr., 2006; 9:875–881.

Maskarinec G., et al. Trends of breast cancer incidence and risk factor prevalence over 25 years. Breast Cancer Res. Treat., 2006; 98:45–55.

Mason P., et al. Induction of ovulation with pulsatile luteinising hormone releasing hormone. Br. Med. J. (Clin Res Ed), 1984; 288:181–5.

Matsubara Y., Matsubara K. Estrogen and progesterone play pivotal roles in endothelial progenitor cell proliferation. Reprod. Biol. Endocrinol., 2012; 10:2.

Mau G. Progestins during pregnancy and hypospadias. Teratology, 1981; 24:285–287.

Mauvais-Jarvis P., et al. In vivo studies on progesterone metabolism by human skin. J. Clin. Endocrinol. Metab., 1969; 29:1580–1585.

Mauvais-Jarvis P., Kuttenn F., Baudot N. Inhibition of testosterone conversion to dihydrotestosterone in men treated pecutaneously by progesterone. J. Clin. Endocrinol. Metab., 1974; 38:142–147.

Mauvais-Jarvis P., Wepierre J., Vickers C. Percutaneous Absorption of Steroids. Academic Press, NY, 1980.

Maxson W. S., et al. Textbook of Gynecology, 2nd ed. Philadelphia: W.B. Saunders, 2000:513–4.

Maxson W. S., Hargrove J. T. Bioavailability of oral micronized progesterone. Fertil. Steril., 1985; 44:622–626.

Maybin J. A., Critchley H. O. Progesterone: a pivotal hormone at menstruation. Ann. NY. Acad. Sci., 2011; 1221:88–97.

Mayol J. M., et al. Progesterone Inhibits Chloride Transport in Human Intestinal Epithelial Cells. World. J. Surg., 2002; 26:652–656.

McCarthy M. M. Estradiol and the developing brain. Physiol. Rev., 2008; 88:91–124.

McCarthy S. M., Foote R. H., Maurer R. R. Embryo mortality and altered uterine luminal proteins in progesterone-treated rabbits. Fertil. Steril., 1977; 28:101–107.

McCord M. L., et al. Single serum progesterone as a screen for ectopic pregnancy: exchanging specificity and sensitivity to obtain optimal test performance. Fertil. Steril., 1996; 66:513–516.

McCracken J. A., Custer E. E., Lamsa J. C. Luteolysis: a neuroendocrine-mediated event. Physiol. Rev., 1999; 79 (2):263–323.

McEwen B. S., Alves S. E. Estrogen actions in the central nervous system. Endocr. Rev., 1999; 20:279–307.

McEwen B. S., et al. Ovarian steroids and the brain: implications for cognition and aging. Neurology, 1997; 48:S8–15.

McEwen B. S. How do sex and stress hormones affect nerve cells? Ann. NY. Acad. Sci.,1994;743:1–16.

McFarlane J. M., Williams T. M. Placing premenstrual syndrome in perspective. Psychology of Women Quarterly, 1994; 18:339–373.

McLean C. P., Anderson E. R. Brave men and timid women? A review of the gender differences in fear and anxiety. Clinical Psychology Review, 2009; 29:496–505.

Medina M., et al. Estradiol and progesterone receptors in mammary cancer. Arch. Invest. Med. (Mex), 1987; 18:235–240.

Mehasseb M. K., et al. Enhanced invasion of stromal cells from adenomyosis in a three-dimensional coculture model is augmented by the presence of myocytes from affected uteri. Fertil. Steril., 2010; 94:2547–2551.

Meis P. J., et al. Prevention of recurrent preterm delivery by 17-alpha-hydroxyprogesterone caproate. N. Engl. J. Med., 2003 348:2379–2385.

Meites J., et al. Effects of corpora lutea removal and replacement with progesterone on pregnancy in goats. J. Anim. Sci., 1951; 10:411–416.

Melcangi R. C., et al. Effects of neuroactive steroids on myelin of peripheral nervous system. J. Steroid. Biochem. Mol. Biol., 2003; 85:323–327.

Mercola J. Complications regarding progesterone cream. www.mercola.com, 2004

Merlino A. A., et al. Nuclear progesterone receptors in the human pregnancy myometrium: evidence that parturition involves functional progesterone withdrawal mediated by increased expression of progesterone receptor-A. J. Clin. Endocrinol. Metab., 2007; 92 (5):1927–1933.

Mertens H. J., Heineman M. J., Evers J. L. The expression of apoptosis-related proteins Bcl-2 and Ki67 in endometrium of ovulatory menstrual cycles. Gynecologic and obstetric investigation. 2002; 53:224–230.

Mesiano S. Myometrial progesterone responsiveness and the control of human parturition. J. Soc. Gynecol. Investig., 2004; 11:193–202.

Mesiano S. Myometrial progesterone responsiveness. Semin. Reprod. Med., 2007; 25 (1):5–13.

Metcalf M. G., Evans J. J., Mackenzie J. A. Indices of ovulation: comparison of plasma and salivary levels of progesterone with urinary pregnanediol. J. Endocrinol., 1984; 100:75–80.

Metzger D. A., et al. Association of endometriosis and spontaneous abortion: effect of control group selection. Fertil. Steril., 1986; 45:18–22.

Meyers-Walen V.N. Genetic of sexual differentiation and anomalies in dogs and cats. J. Reprod. Fertil. Suppl., 1993; 47:441–452.

Michaelis J., et al. Prospective study of suspected associations between certain drugs administered during early pregnancy and congenital malformations. Teratology, 1983; 27:57–64.

Mikkelsen A. L., Smith S., Lindenberg S. Impact of estradiol and inhibin A concentrations on pregnancy rate in in-vitro oocyte maturation. Hum. Reprod., 2000; 15:1685–1690.

Miles R. A., et al. Pharmacokinetics and endometrial tissue levels of progesterone after administration by intramuscular and vaginal routes: a comparative study. Fertil. Steril., 1994; 62:485–490.

Mills A. A., et al. Characterization of progesterone receptor isoform expression in fetal membranes. Am. J. Obstet. Gynecol., 2006; 195 (4):998–1003.

Minici F., et al. Endometriosis and human infertility: a new investigation into the role of eutopic endometrium. Human Reproduction, 2008; 23:530–537.

Mishell D. R. Jr. Premenstrual disorders: epidemiology and disease burden. Am. J. Manag. Care, 2005; 11 (16 Suppl):S473–S479.

Mitchell V. L., Gershwin L. J. Progesterone and environmental tobacco smoke act synergistically to exacerbate the development of allergic asthma in a mouse model. Clin. Exp/ Allergy, 2007; 37:276–286.

Mittal K., Demopoulos R. I. MIB-1 (Ki-67), p53, estrogen receptor, and progesterone receptor expression in uterine smooth muscle tumors. Hum. Pathol., 2001; 32:984–987.

Mittwoch U. Sex determination and sex reversal: genotype, phenotype, dogma and semantics. Hum. Genet., 1992; 89 (5):467–479.

Moghadam B. K., Hersini S., Barker B. F. Autoimmune progesterone dermatitis and stomatits. Oral. Surg. Oral. Med. Oral. Pathol., 1998; 85:537–541.

Moline M. L., Zendell S. M. Evaluating and managing premenstrual syndrome. Medscape Womens Health, 2000; 5 (2):1.

Mollitch M. Hormonal changes and endocrine testing in pregnancy. In: Endocrinology. Edited by DeGroot L., Jameson J. Philadelphia: WB Saunders Company; 2001:2489–2490.

Moltz H., Levin R., Leon M. Differential effects of progesterone on the maternal behavior of primiparous and multiparous rats. J. Comp. Physiol. Psychol., 1969; 67:36–40.

Monteleone P., et al. Allopregnanolone concentrations and premenstrual syndrome. Europ. J. Endocr., 2000; 142:269–273.

Montgomery J. C., et al. Effect of oestrogen and testosterone implants on psychological disorders in the climacteric. Lancet, 1987; 1:297–299.

Morán C., et al. Estradiol and progesterone endometrial receptors and body fat distribution in obese women. Gynecol. Obstet. Invest., 1996; 23:771–772.

Moran M. H., Goldberg M., Smith S. S. Progesterone withdrawal II: insensitivity to the sedative effects of a benzodiazepine. Brain Research, 1998; 807:91–100.

Morishita S. Prompt effect of progesterone on the adrenergic response of smooth muscles. Jpn. J. Pharmacol., 1986; 42 (2):289–296.

Morris D., Diskin M. Effect of progesterone on embryo survival. Animal, 2008; 2:8:1112–1119.

Morris N. M., Udry J. R., Underwood L. E. A study of the relationship between coitus and the luteinizing hormone surge. Fertil. Steril., 1977; 28:440–442.

Moskowitz D. A comprehensive review of the safety and efficacy of bioidentical hormones for the management of menopause and related health risks. Alt. Med. Rev., 2006; 11 (3):208–223.

Moster D., Lie R. T., Markestad T. Long-term medical and social consequences of preterm birth. N. Engl. J. Med., 2008; 359:262–273.

Mote P. A., et al. Colocalization of progesterone receptors A and B by dual immunofluorescent histochemistry in human endometrium during the menstrual cycle. J. Clin. Endocrino. Metab., 1999; 84:2963–2971.

Mote P. A., et al. Heterogeneity of progesterone receptors A and B expression in human endometrial glands and stroma. Hum. Reprod., 2000; 15 (Suppl 3):48–56.

Mote P. A., Graham J. D., Clarke C. L. Progesterone receptor isoforms in normal and malignant breast. Ernst Schering Foundation Symposium Proceedings, 2007; 77–107.

Moyer D. L., Felix J. C. The effects of progesterone and progestins on endometrial proliferation. Contraception, 1998; 57:399–403.

Mucci L. A., et al. Pregnancy estriol, estradiol, progesterone and prolactin in relation to birth weight and other birth size variables (United States). Cancer Causes Control, 2003; 14 (4):311–318.

Mueller M. D., et al. Neutrophils infiltrating the endometrium express vascular endothelial growth factor: potential role in endometrial angiogenesis. Fertil. Steril., 2000; 74:107–112.

Mui Lam P. O., et al. Effects of early luteal-phase vaginal progesterone supplementation on the outcome of in vitro fertilization and embryo transfer. Gynecol. Endocrinol., 2008; 24 (12):674–680.

Mulac-Jericevic B., Conneely O. M. Reproductive tissue selective actions of progesterone receptors. Reproduction, 2004; 128:129–146.

Mulac-Jericevic B., et al. Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform. Science, 2000; 289:1751–1754.

Muleba N., et al. Human chorionic gonadotropin levels following spontaneous abortion in the first trimester. Am. J. Obstet. Gynecol., 2005; 193:S116–S117.

Nagasawa H., et al. Ovarian dependence of the stimulatory effect of neonatal hormone treatment on plasma levels of prolactin in female mice. J. Endocrinol., 1978; 79:391–392.

Nahoul K., et al. Profiles of plasma estrogens, progesterone and their metabolites after oral or vaginal administration of estradiol or progesterone. Maturitas, 1993; 16:185–202.

Nakamura M. The mechanism of sex determination in vertebrates — are sex steroids the key-factor? J. Exp. Zool., 2010; 131A:381–398.

Nappi R. E., et al. Luteal phase dysphoric disorder and premenstrual syndrome. It J. Psych., 2009; 28:27–33.

Nappi R. E., Rivest S. Ovulatory cycle influences the stimulatory effect of stress on the expression of corticotropin-releasing factor receptor messenger ribonucleic acid in the paraventricular nucleus of the female rat hypothalamus. Endocrinology, 1995; 136:4073–4083.

National Collaborating Centre for Women’s and Children’s Health. Fertility assessment and treatment for people with fertility problems (Commissioned by the National Institute for Clinical Excellence). RCOG press, 2004.

Navot D., et al. Hormonal manipulation of endometrial maturation. J. Clin. Endocrinol. Metab., 1989; 68:801–807.

Neal-Perry G., Nejat E., Dicken C. The neuroendocrine physiology of female reproductive aging: An update. Maturitas, 2010; 67:34–38.

Near A. M., et al. Progesterone Receptor Gene Polymorphisms and Risk of Endometriosis: Results from an International Collaborative Effort. Fertil. Steril., 2011; 95 (1):40–45.

Nedrow A., et al. Complementary and alternative therapies for the management of menopause-related symptoms. Arch. Intern. Med., 2006; 166 (14):1453–1465.

Nelson M. M., Forfar J. O. Epidemiology of drug taken by pregnant women: drugs that may affect the fetus adversely. Clin. Pharmacol., 1971; 14:632–642.

Neulen J., Breckwoldt M. Placental progesterone, prostaglandins and mechanisms leading to initiation of parturition in the human. Exp. Clin. Endocrinol., 1994; 102:195–202.

Nillius S. J., Johansson E. D. B. Plasma progesterone levels after intramuscular or rectal administration of progesterone. Acta Obstet. Gynecol. Scand., 1971; 50:46.

Nillni Y. I., et al. Anxiety sensitivity, the menstrual cycle, and panic disorder: a putative neuroendocrine and psychological interaction. Rohan Clin. Psychol. Rev., 2011 November; 31 (7):1183–1191.

Niswender G. D., et al. Judge, jury and executioner: the auto-regulation of luteal function. Soc. Reprod. Fertil. Suppl., 2007; 64:191–206.

Niswender G. D., et al. Mechanisms controlling the function and life span of the corpus luteum. Physiol. Rev., 2000; 80 (1):1–29.

Niswender G. D. Molecular control of luteal secretion of progesterone. Reproduction, 2002; 123:333–339.

Niu Z., et al. Progesterone levels on oocyte retrieval day can predict the quantity of viable embryos but not pregnancy outcome of intracytoplasmic sperm injection. Gynecol. Endocrinol., 2008; 24 (8):452–458.

Nora A. H., Nora J. J. A syndrome of multiple congenital anomalies associated with teratogenic exposure. Arch. Environ. Health, 1975; 30:17–21.

North American Menopause Society. Estrogen and progestogen use in postmenopausal women: 2010 position statement of The North American Menopause Society. Menopause, 2010; 17:242–255.

Northen A. T., et al. National Institute of Child Health and Human Development (NICHD). Maternal-Fetal Medicine Units (MFMU). Network: follow-up of children exposed in utero to 17 alpha-hydroxyprogesterone caproate compared with placebo. Obstet. Gynecol., 2007; 110:865–872.

Norwitz E. R., Caughey A. B. Progesterone Supplementation and the Prevention of Preterm Birth. Rev. Obstet. Gynecol., 2011; 4 (2):60–72.

Norwitz E. R., Schust D. J., Fisher S. J. Implantation and the survival of early pregnancy. N. Engl. J. Med., 2001; 345:1400–1408.

Nosarka S., Kruger T., Siebert I., Grové D. Luteal phase support in in vitro fertilization: meta-analysis of randomized trials. Gynecol. Obstet. Invest., 2005; 60:67–74.

Novak E. An Appraisal of Ovarian Therapy. Endocrinology, 1922; 6:599.

Nowak R. A. Novel therapeutic strategies for leiomyomas: targeting growth factors and their receptors. Environ Health Perspect, 2000; 108 Suppl 5:849–853.

Ntrivalas E. I., et al. Status of peripheral blood natural killer cells in women with recurrent spontaneous abortions and infertility of unknown aetiology. Hum. Reprod., 2001; 16:855–861.

Numan M. Progesterone inhibition of maternal behavior in the rat. Horm. Behav., 1978; 11:209–231.

Nyboe Andersen A., et al. Progesterone supplementation during early gestation after IVF or ICSI has no effect on the delivery rates: a randomized controlled trial. Hum. Reprod 2002; 17:357–361.

O’Brien J. M., et al. Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial. Ultrasound Obstet. Gynecol., 2007; 30:687–696.

Oates-Whitehead R. M., Haas D. M., Carrier J. A. K. Progestogen for preventing miscarriage. Cochrane Database Syst. Rev., 2003; 4:CD003511.

Oehninger S., et al. A sequential analysis of the effect of progesterone on specific sperm functions crucial to fertilization in vitro in infertile patients. Hum. Reprod., 1994; 9:1322–1327.

Office of Environmental Health Hazard Assessment (OEHHA). Evidence for Developmental and Reproductive Toxicity of Progesterone. 2004. Available at http://www.oehha.org/prop65/hazard_ident/pdf_zip/progeshid5.pdf.

Ogihara T., Matsumoto S., Ohnishi S. Functional characterization of active transport of progesterone to adrenal cells. JPP, 2004; 56:79–84.

Ojeda S. R. Female Reproductive Function. In Text Book Endocrine Physiology. Edited by: Graffin J. E. and Ojeda S.R. Oxford, New York: Oxford University Press; 5 2004:186–225.

Okada A., et al. Ef fect of estrogens on ontogenetic expression of progesterone receptor in the fetal female rat reproductive tract. Mol. Cell. Endocrinol., 2002; 195:55–64.

Omar M. H., et al. Dydrogesterone in threatened abortion: pregnancy outcome. J. Steroid. Biochem. Mol. Biol., 2005; 97:421–425.

O’Neill T. Progesterone prophylaxis? BJP, 1990; 157:776–777.

Oren-Benaroya R., et al. The sperm chemoattractant secreted from human cumulus cells is progesterone. Hum. Reprod., 2008; 23:2339–2345.

Osakay T., Kutluay L., Kaptanoglu A., Karabacak O. Autoimmune progesterone dermatitis. Eu. J. Dermatol., 2002; 6:589–591.

Osman R. A., et al. Steroid induced exocytosis: the human sperm acrosome reaction. Biochem. Biophys. Res. Commun., 1989; 160:828–833.

Osteen K. G., Bruner-Tran K. L., Eisenberg E. Reduced progesterone action during endometrial maturation: a potential risk factor for the development of endometriosis. Fertil. Steril., 2005; 83:529–537.

Ottoson U. B., et al. Serum levels of progesterone and some of its metabolites including deoxycorticosterone after oral and parenteral administration. Br. J. Obstet. Gynecol., 1984; 91:1111–1119.

Paitz R. T., et al. Progesterone metabolites, «xenobiotic-sensing» nuclear receptors, and the metabolism of maternal steroids. General and Comparative Endocrinology, 2010; 166:217–221.

Pakulski C. Neuroprotective properties of sex hormones. Anaesthesiology Intensive Therapy, 2011; XLIII,2:102–106.

Pall M., et al. Timedependent ovulation inhibition of a selective progesterone-receptor antagonist (Org 31710) and effects on ovulatory mediators in the in vitro perfused rat ovary. Biology of Reproduction, 2000; 63:1642–1647.

Panay N., Studd J. Progestogen intolerance and compliance with hormone replacement therapy in menopausal women. Hum. Reprod. Update, 1997; 3:159–171.

Panay N., Studd J. W. The psychotherapeutic effects of estrogens. Gynecol. Endocrinol., 1998; 12:353–365.

Papanikolaou E. G., et al. Progesterone rise on the day of human chorionic gonadotropin administration impairs pregnancy outcome in day 3 single-embryo transfer, while has no effect on day 5 single blastocyst transfer. Fertil. Steril., 2009; 91:949–952.

Parazzini F. Oestrogens and progesterone concentrations and risk of ectopic pregnancy: an epidemiological point of view. Hum. Reprod., 1996; 11:236–238.

Park K.-H., et al. Ca2+ signaling tools acquired from prostasomes are required for progesterone-induced sperm motility. Sci. Signal, 2011; 4:31.

Pastor C. L., et al. Polycystic ovary syndrome: evidence for reduced sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone. J. Clin. Endocrinol. Metab., 1998; 83:582–590.

Pau K. Y., et al. Oestrogen upregulates noradrenaline release in the mediobasal hypothalamus and tyrosine hydroxylase gene expression in the brainstem of ovariectomized rhesus macaques. J. Neuroendocrinol, 2000; 12:899–909.

Pauli B. D., et al. Infl uence of the menstrual cycle on airway function and normal subjects. Am. Rev., Respir. Dis., 1989; 140:358–362.

Peacock A., Alvi N. S., Mushtaq T. Period problems: disorders of menstruation in adolescents. Arch. Dis. Child, 2012; 97:554–560.

Peck J. D., et al.Steroid hormone levels during pregnancy and incidence of maternal breast cancer. Cancer Epidemiol. Biomarkers Prev., 2002; 11 (4):361–368.

Peluso J. J. Multiplicity of progesterone’s actions and receptors in the mammalian ovary. Biol. Reprod., 2006; 75:2–8.

Pensler J. M., et al. Osteoclasts isolated from membranous bone in children exhibit nuclear estrogen and progesterone receptors. J. Bone Miner Res., 1990 5:797–802.

Penzias A. S., Alper M. M. Luteal support with vaginal micronized progesterone gel in assisted reproduction. Reprod. Biomed. Online, 2003; 6:287–295.

Penzias A. S. Luteal phase support. Fertil. Steril., 2002; 77:318–323.

Pereira Vega A., et al. Variability in the prevalence of premenstrual asthma. Eur. Respir. J., 2010; 35:980–986.

Pereira-Vega A., et al. Premenstrual Asthma and Female Sex Hormones. J. Investig. Allergol. Clin. Immunol., 2012; 22 (6):437–459.

Perheentupa A., Huhtaniemi I. Aging of the human ovary and testis. Molecular and Cellular Endocrinology, 2009; 299 (1):2–13.

Perkins S. L., et al. Comparison of serum progesterone as an indicator of pregnancy nonviability in spontaneously pregnant emergency room and infertility clinic patient populations. Fertil. Sterilt., 2000; 73:499–504.

Petrelli E. A., Forbes T. R. Toxicity of progesterone to mouse fetuses. Endocrinol., 1964; 75:145–146.

Pfeifer S. M., Strauss J. F. III. Progestins In: Reproductive Endocrinology, surgery and technology, pp 495–503. Eds E. Y. Adashi, J. A. Rock and Z. Rosenwaks. Philadelphia: Lippincott-Raven, 1996.

Piccinni M. P., et al. Progesterone favors the development of human T helper cells producing Th2-type cytokines and promotes both IL-4 production and membrane CD30 expression in established Th1 cell clones. J. Immunol., 1995; 155:128–133.

Pichon M. F., et al. Prognostic value of progesterone receptors in primary breast cancer. Recent Results Cancer Res., 1984; 91:186–191.

Picton H. M., et al. The in vitro growth and maturation of follicles. Reproduction, 2008; 136:703–715.

Picton H. M. Activation of follicle development: the primordial follicule. Theriogenology, 2001; 55:1193–1210.

Pierik F., et al. Environmental risk factors for cryptorchidism and hypospadias. Birth Defects Res. Part A, 2004; 70:293.

Pincus G., et al. Fertility control with oral medication. Am. J. Obstet. Gynecol., 1958; 75:1333–1346.

Pintiaux A., et al. Gynecological uses of a new class of steroids: the selective progesterone receptor modulators. Gynecol. Endocrinol., 2009; 25 (2):67–73.

Piotrowski J. Experimental investigations on the effect of progesterone on embryonal development. Part II. Investigations carried out on rabbits. Folia Biol. (Krakow), 1968a; 16:335–342.

Piotrowski J. The effect of progesterone on the foetal development of rats on the Wistar strain. Part 3. Folia Biol. (Krakow), 1968b; 16:343–353.

Pitts C. J., Kearns A. E. Update on Medications With Adverse Skeletal Effects. Mayo Clin. Proc., 2011; 86 (4):338–343.

Pointis G., et al. Ef fect of maternal progesterone exposure on fetal testosterone in mice. Biol. Neonate, 1984; 45:203–208.

Pointis G., et al. Effect of natural progesterone treatment during pregnancy on fetal testosterone and sexual behavior of the male offspring in the mouse. Dev. Pharmacol. Ther., 1987; 10:385–392.

Polednak A. P., Janerich D. T. Maternal characteristics and hypospadias: a case-control study. Teratology, 1983; 28:67–73.

Polgar B, et al. Urinary progesterone-induced blocking factor concentration is related to pregnancy outcome. Biol Reprod 2004;71:1699–1705.

Pollow K., et al. Gestodene: a novel synthetic progestin; characterization of binding to receptor and serum proteins. Contraception, 1989; 40:325–341.

Polson D. W., et al. Vaginal progesterone as luteal phase support in an IVF/GIFT programme. Eur. J. Obstet. Gynecol. Reprod. Biol., 1992; 46:35–38.

Ponnampalam A. P., et al. Molecular classification of human endometrial cycle stages by transcriptional profiling. Mol. Hum. Reprod.,2004; 10:879–893.

Porter T. F., Scott J. R. Evidence-based care of recurrent miscarriage. Best Pract. Res. Clin. Obstet. Gynecol., 2005; 19:85–101.

Potdar N., Konje J. C. The endocrinological basis of recurrent miscarriage. Curr. Opin. Obstet. Gynecol., 2005; 17:424–428.

Potischman N., et al. Pregnancy hormone concentrations across ethnic groups: implications for later cancer risk. Cancer Epidemiol. Biomarkers Prev., 2005; 14 (6):1514–1520.

Pouly J. L., et al. Luteal support after invitro fertilization: Crinone 8 %, a sustained release vaginal progesterone gel, versus Utrogestan, an oral micronized progesterone. Hum. Reprod., 1996; 11:2085–2089.

Pritts E. A., Atwood A. K. Luteal phase support in infertility treatment: a meta-analysis of the randomized trials. Hum. Reprod., 2002; 17:2287–2299.

Proctor A., et al. Effect of progesterone supplementation in early pregnancy on the pregnancy outcome after in vitro fertilization. Fertil. Steril., 2006; 85:1550–1552.

Progesterone. National Toxicology Program, Department of Health and Human Services.Report on Carcinogens, Twelfth Edition, 2011.

Publicover S., Barratt C. Progesterone’s gateway into sperm. Nature, 2011; 471:313–314.

Publicover S. J., Barratt C. L. R. Sperm motility: things are moving in the lab! Molecular Human Reproduction, 2011; 17 (8):453–456.

Qi H., et al. All four CatSper ion channel proteins are required for male fertility and sperm cell hyperactivated motility. Proc. Natl. Acad. Sci. USA, 2007; 104:1219–1223.

Quack K. C., et al. Leukocyte activation in the decidua of chromosomally normal and abnormal fetuses from women with recurrent abortion. Hum. Reprod., 2001; 16:949–955.

Raber L. Steroid industry honored. ACS News, 1999; 77:78–80.

Radulesco J. C. Dydrogesterone in treatment of hypohormonal pregnancy. Mars. Med., 1970; 107:191–196.

Raghupathy R., et al. Cytokine production by maternal lymphoctes during normal human pregnancy and in unexplained recurrent spontaneous abortion. Hum. Reprod., 2000; 15:713–718.

Raghupathy R., et al. Modulation of cytokine production by dydrogesterone in lymphocytes from women with recurrent miscarriage. Br. J. Obstet. Gynecol., 2005; 112:1096–1101.

Raghupathy R. Th1-type immunity is incompatible with successful pregnancy. Immunol. Today, 1997; 18:478–482.

Ragusa A., et al. Progesterone supplement in pregnancy: an immunologic therapy? Lupus, 2004; 13:639–642.

Rai R., et al. Recurrent miscarriage — an aspirin a day? Hum. Reprod., 2000; 15:2220–2223.

Rajaram R. D., Brisken C. Paracrine signaling by progesterone. Mol. Cel. Endocrinol., 2012; 357:80–90.

Ralt D., et al. Chemotactic and chemokinesis of human spermatozoa to follicular factors. Biol. Reprod., 1994; 50:774–785.

Ralt D., et al. Sperm attraction to a follicular factor (s) correlates with human egg fertilizability. Proc. Natl. Acad. Sci. USA, 1991; 88:2840–2844.

Raman-Wilms L., et al. Fetal genital effects of first-trimester sex hormone exposure: a metaanalysis. Obstet. Gynecol., 1995; 85:141–149.

Rapkin A. J., et al. Relationships among self-rated Tanner staging, hormones, and psychosocial factors in health female adolescents. J. Pediatr. Adolesc. Gynecol., 2006; 19:181–7.

Rapkin A. J. YAZ in the treatment of premenstrual dysphoric disorder. J. Reprod. Med., 2008; 53:729–741.

Read G. F., et al.The use of salivary progesterone assays in the assessment of ovarian function in postmenarcheal girls. J. Endocrinol., 1984; 102:265–268.

Reddy R., et al. Oocyte-specific deletion of Pten causes premature activation of the primordial follicle pool. Science, 2008; 319 (1):611–613.

Rees M. C. P. Human Menstruation and Eicosanoids. Reprod. Fertil. Dev., 1990; 2:467–476.

Reilly W., et al. Phallic urethra in female pseudohermaphroditism. J. Dis. Child, 1958; 95:9–17.

Reins M. S., Barbieri R. L., Friedman A. J. Progesterone: a critical role in the pathogenesis of uterine myomas. Am. J. Obstet. Gynecol., 1995; 172 (1 Pt 1):14–18.

Reins M. S. Advances in uterine leiomyoma research: the progesterone hypothesis. Environ Health Perspect, 2000; 108 Suppl 5:791–793.

Reiss S., McNally R. J. The expectancy model of fear. In: Reiss, S.; Bootzin, R.R., editors. Theoretical issues in behavior therapy. New York: Academic Press, 1985; 107–122.

Ren D. J., et al. A sperm ion channel required for sperm motility and male fertility. Nature, 2001; 413:603–609.

Resseguie L. J., et al. Congenital malformations among offspring exposed in utero to progestins, Olmsted County, Minnesota, 1936–1974. Fertil. Steril., 1985; 43:514–519.

Revesz C., Chappel C., Gaudry R. Masculinization of female fetuses in the rat by progestational compounds. Endocrinology, 1960; 66:140–143.

Reznikoff-Etievant M. F., et al. Low vitamin B12 level as risk factor for very early recurrent abortion. Eur. J. Obstet. Gynecol. Reprod. Biol., 2002; 104:156–159.

Rhodes M. E., Frye C. A. Inhibiting progesterone metabolism in the hippocampus of rats in behavioral estrus decreases anxiolytic behaviors and enhances exploratory and antinociceptive behaviors. Cognitive, Affective, & Behavioral Neuroscience, 2001; 1:287–296.

Richer J. K., et al. Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells. Journal of Biological Chemistry, 2002; 277:5209–5218.

Riddick D. H., et al. De novo synthesis of prolactin by human decidua. Life Sci., 1978; 23:1913–1921.

Riss P. A., Radivojevic K., Bieglmayer C. Serum progesterone and human chorionic gonadotropin in very early pregnancy: implications for clinical management. Eur. J. Obstet. Gynecol. Reprod. Biol., 1989; 32:71–77.

Rivier C., Rivest S. Effect of stress on the activity of the hypothalamicpituitary-gonadal axis peripheral and central mechanisms. Biol. Reprod., 1991; 45:523–532.

Robiero L. S., Izquierdo L. Effect of progesterone on the cleavage rate of mouse embryos in vitro. J. Reprod. Fert., 1976; 46:475–476.

Robker R. L., et al. Progesterone-regulated genes in the ovulation process: ADAMTS-1 and cathepsin L proteases. Proc. Natl. Acad. Sci. USA, 2000; 97:4689–4694.

Roblero L. S., Garavagno A. C. Effect of oestradiol-17β and progesterone on oviductal transport and early development of mouse embryos. J. Reprod. Fert., 1979; 57:91–95.

Roblero L. S. Effect of progesterone in vivo upon the rate of cleavage of mouse embryos. Reprod. Fert., 1973; 35:153–155.

Rock J. A., et al. Fetal malformations following progesterone therapy during pregnancy: a preliminary report. Fertil. Steril., 1985; 44:17–19.

Rogers P. A. Endometrial vasculature in Norplant users. Hum. Reprod., 1996; 11 (Suppl 2):45–50.

Rojas-Marcos P. M., David R., Kohn B. Hormonal effects in infants conceived by assisted reproductive technology. Pediatrics, 2005; 116:190–194.

Roman E. A., Alberman E., Pharoah P. O. Pregnancy order and fetal loss. BMJ, 1980; 280:715.

Romero R., et al. Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient data. Am. J. Obstet. Gynecol., 2012; 206:124.e1–19.

Rose D. P., et al. High-fiber diet reduces serum estrogen concentrations in premenopausal women. Am. J. Clin. Nutr., 1991; 54:520–525.

Ross, et al. Is it possible to estimate the minimal clinically important treatment effect needed to change practice in preterm birth prevention? Results of an obstetrician survey used to support the design of a trial. BMC Medical Research Methodology, 2012; 12:31.

Rossouw J. E., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA, 2002; 288:321–333.

Rouse D. J., et al. A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins. N. Engl. J. Med., 2007; 357:454–61.

Rubinow D. R., et al. Changes in plasma hormones across the menstrual cycle in patients with menstrually related mood disorder and in control subjects. AJOG, 1988; 158:5–11.

Runic R., et al. Effects of Norplant on endometrial tissue factor expression and blood vessel structure. J. Clin. Endocrinol. Metab., 2000; 85:3853–3859.

Ryan K. J., Smith O. W. Biogenesis of estrogens by the human ovary. II. Conversion of progesterone-4-C-14 to estrone and estradiol. J. Biol. Chem., 1961; 236:710–714.

Saito S., Sakai M. Th1/Th2 balance in preeclampsia. Reprod. Immunol., 2003; 59:161–173.

Saito S. Cytokine network at the feto-maternal interface. J. Reprod. Immunol., 2000; 47:87–103.

Salafia C., et al. Placental and decidual histology in spontaneous abortion: detailed description and correlations with chromosome number. Obstet. Gynecol., 1993; 82:295–303.

Salamonsen L. A., Giudice L. C. ’The Curse’: A 21st Century Perspective of Models of Its Molecular Basis. Endocrinology, 2010; 151 (9):4092–4095.

Salamonsen L. A., et al. Production of endometrial matrix metalloproteinases but not their tissue inhibitors is modulated by progesterone withdrawal in an in vitro model for menstruation The Journal of clinical endocrinology and metabolism, 1997; 82:1409–1415.

Salamonsen L. A., Lathbury L. J. Endometrial leukocytes and menstruation. Hum. Reprod. Update, 2000; 6 (1):16–27.

Salazar E. L., Calzada L. The role of progesterone in endometrial estradiol- and progesterone-receptor synthesis in women with menstrual disorders and habitual abortion. Gynecol. Endocrinol., 2007; 23 (4):222–225.

Salazar E. L., Calzada S. L., Escontria M. Estradiol/androgen receptors during aging: microsomal distribution in human benign prostatic hypertrophy. Arch. Androl., 2005; 51:49–53.

Salazar E. L., et al. Estrogen receptor in displastic and malignant cervical tissue: expression, localisation and prognostic significance. Med. Sci. Res., 1996; 24:523–524.

Salazar E. L., Mercado E., Calzada S. L. Prostatic cancer/benign prostatic hypertrophy. Subcellular distribution of estradiol/androgen receptors. Arch. Androl., 2005; 51:135–139.

Salazar E. L., Paredes., Calzada L. Endometrial thickness of postmenopausal breast cancer patients treated with tamoxifen. Gynecol. Endocrinol., 2005; 21:312–316.

Salker M., et al. Natural selection of human embryos: impaired decidualization of the endometrium disables embryo-maternal interactions and causes recurrent pregnant loss. PLoS One, 2010; 5 (4):e10287.

Salomon L. J., et al. Changes in progesterone-induced-blocking factor expression rates following mifepristone administration in termination of pregnancy at 5 to 8 weeks. J. Matern. Fetal. Neonatal. Med., 2005; 17:353–356.

Samalecos A., Gellersen B. Systematic expression analysis and antibody screening do not support the existence of naturally occurring progesterone receptor (PR) — C, PR-M, or other truncated PR isoforms. Endocrinol., 2008; 149:5872–5887.

Sanchez-Ramos L., Kaunitz A. M., Delke I. Progestational agents to prevent preterm birth: a meta-analysis of randomized controlled trials. Am. J. Obstet. Gynecol., 2005; 105:273–279.

Santen R. J., et al. Postmenopausal hormone therapy: an Endocrine Society scientific statement. J. Clin. Endocrinol. Metab., 2010; 95:s1-s66.

Sarkar N. N. The state-of-the-art of emergency contraception with the cutting edge drug. German Medical Science, 2011; 9:1–7.

Sauer M. V., et al. Endometrial responses to various hormone replacement regimens in ovarian failure patients preparing for embryo donation. Int. J. Gynecol. Obstet., 1991; 35:61–68.

Savaris R. F., et al. Progesterone resistance in PCOS endometrium: a microarray analysis in clomiphene citrate-treated and artificial menstrual cycles. J. Clin. Endocrinol. Metabol., 2011; 96 (6):1737–1746.

Scatchard G. The attraction of proteins for small molecules and ions. Ann. NY. Acad. Sci., 1949; 51:660–672.

Schedin P. Pregnancy-associated breast cancer and metastasis. Nat. Rev. Cancer, 2006; 6:281–291.

Schindler A. E., et al. Classification and pharmacology of progestins. Maturitas, 2003; 46 (Suppl 1):S7–S16.

Schindler A. E. Non-contraceptive benefits of hormonal contraceptives. Minerva Ginecol., 2010; 62:319–329.

Schmidt K. L., et al. Progesterone supplementation during early gestation after in vitro fertilization has no effect on the delivery rate. Fertil. Steril., 2001; 75:337–341.

Scholer H. F., de Wachter A. Evaluation of androgenic properties of progestational compounds in the rat by the female foetal masculinisation test. Acta Endocrinol. (Copenh.), 1961; 38:128–136.

Schoolcraft W., et al. Lower pregnancy rate with premature luteinisation during pituitary suppression with leuprolide acetate. Fertil. Steril., 1991; 55:563–566.

Schumacher M., et al. Genomic and membrane actions of progesterone: implications for reproductive physiology and behavior. Behav. Brain. Res., 1999; 105:37–52.

Schumacher M., et al. Progesterone and progestins: neuroprotection and myelin repair. Current Opinion in Pharmacology, 2008; 8:740–746.

Schumacher M., et al. Progesterone: Therapeutic opportunities for neuroprotection and myelin repair. Pharmacology & Therapeutics, 2007; 116:77–106.

Schwarzenbach H., et al. Stimulatory effect of progesterone on the expression of steroidogenic acute regulatory protein in MA-10 Leydig cells. Biol. Reprod., 2003; 68:1054–1063.

Schweppe K. W. Progestins and uterine leiomyoma. Gynecol. Endocrinol., 1999; 13 Suppl 4:21–24.

Scialli A. R. Developmental effects of progesterone and its derivatives. Reprod. Toxicol., 1988; 2:3–11.

Scott J. R. Immunotherapy for recurrent miscarriage. Cochrane Database Syst. Rev., 2003; 1:CD000112.

Scully C., et al. Metabolism of progesterone by human leukocytes. Clinical Immunology and Immunopthology, 1982; 22:147–151.

Shahar E., Bergman R., Pollack S. Autoimmune progesterone dermatitis: effective prophylactic treatment with danazol. Int. J. Dermatol., 1997; 36:708–711.

Shanker Y. G., Sharma S. C., Rao A. J. Expression of progesterone receptor mRNA in the first trimester human placenta. Biochem. Mol. Biol. Int., 1997; 42:1235–1240.

Shaw W. The Origin of the Lutein Cells of the Corpus Luteum. Proc. R. Soc. Med., 1926; 19 (Obstet. Gynecol. Sect.): 22–24.

Sheehan T., Numan M. Estrogen, progesterone, and pregnancy termination alter neural activity in brain regions that control maternal behavior in rats. Neuroendocrinology, 2002; 75:12–23.

Sherman B. M., West J. H., Korenman S. G. The menopausal transition: analysis of LH, FSH, estradiol, and progesterone concentrations during menstrual cycles of older women. J. Clin. Endocrinol. Metabol., 1976; 42:629–636.

Shi J., Simpkins J. W. 17 beta-Estradiol modulation of glucose transporter 1 expression in blood-brain barrier. Am. J. Physiol., 1997; 272:E1016–E1022.

Shirkey H. C. Human experiences related to adverse drug reactions to the fetus or neonate from some maternally administered drugs. Adv. Exp. Med. Biol., 1972; 27:17–30.

Shkolnik K., et al. Reactive oxygen species are indispensable in ovulation. PNAS, January 25, 2011; 108 (4):1462–1467.

Shultz T. D., Howie B. J. In vitro binding of steroid hormones by natural and purified fibers. Nutr. Cancer, 1986; 8:141–147.

Siiteri P. K., Febres F., Clemens L. E. Progesterone and maintenance of pregnancy: is progesterone nature’s immunosuppressant? Ann. NY. Acad. Sci., 1977; 286:384–397.

Sills E. S., Alper M. M., Walsh A. P. H. Ovarian reserve screening in infertility: Practical applications and theoretical directions for research. European Journal of Obstetrics & Gynecology and Reproductive Biology, 2009; 146:30–36.

Silver R. I., et al. In vitro fertilization is associated with an increased risk of hypospadias. J. Urol., 1999; 161:1954–1957.

Silver R. I. Endocrine abnormalities in boys with hypospadias. Adv. Exp. Med. Biol., 2004; 545:45–72.

Šimić N., Santini M. Verbal amd spatial functions during different phases of the menstrual cycle. Psychiatria Danubina, 2012; 24 (1):73–79.

Simon J. A., et al. The absorption of oral micronized progesterone: the effect of food, dose proportionality, and comparison with intramuscular progesterone. Fertil. Steril., 1993; 60:26–33.

Simon J. A. Micronized progesterone: vaginal and oral uses. Clin. Obstet. Gynecol., 1995; 38:902–914.

Simoncini T., et al. Effects of dydrogesterone and of its stable metabolite, 20-a-dihydrogesterone, on nitric oxide synthesis in human endothelial cells. Fertil. Steril., 2006; 86 (Suppl 3):1235–1242.

Simoncini T., et al. In vitro effects of progesterone and progestins on vascular cells. Steroids, 2003; 68:831–836.

Singh M., Su C. Progesterone and neuroprotection. Horm. Behav., 2013; 63 (2):284–290.

Singh M. Progesterone-Induced Neuroprotection. Endocrine, 2006; 29 (2):271–274.

Sirrat G. M. Recurrent miscarriage. Lancet, 1990; 336:673–675.

Sitruk-Ware R. Progestogens in hormonal replacement therapy: new molecules, risks, and benefits. Menopause. 2002; 9:6–15.

Sivin I. Dose- and age-dependent ectopic pregnancy risks with intrauterine contraception. Obstet. Gynecol., 1991; 78:291–298.

Slotta K.H., Ruschig H., Fels E. Reindarstellung der Hormone aus dem Corpusluteum. Berichte Deutsche chemische Gesellschaft, 1934; 67 (7):1270–1273.

Smith L. J., et al. Effects of ovarian steroids and raloxifene on proteins that synthesize, transport, and degrade serotonin in the raphe region of macaques. Neuropsychopharmacology, 2004; 29:2035–2045.

Smitz J., et al. A randomized prospective study comparing supplementation of the luteal phase and early pregnancy by natural progesterone administered by intramuscular or vaginal route. Rev. Fr. Gynecol. Obstet., 1992; 87:507–516.

Snyder J. L., Krishnaswamy G. Autoimmune progesterone dermatitis and its manifestation as anaphylaxis: a case report and literature review. Ann. Allergy Asthma Immunol., 2003; 90:469–477.

Soares C. N., et al. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a doubleblind, randomized, placebo-controlled trial. Arch. Gen. Psychiatry, 2001;58:529–534.

Soares S. R., et al. Cigarette smoking affects uterine receptiveness. Hum. Reprod., 2007; 22:543–547.

Soliz J., Joseph V. Perinatal steroid exposure and respiratory control during early postnatal life. Respir. Physiol. Neurobiol., 2005; 149:111–122.

Somers S. Ageless: The Naked Truth about Bioidentical Hormones. New York, NY: Crown Publishers; 2006.

Sparka M. J., Willis J. Systematic review of progesterone use by midlife and menopausal women. Maturitas, 2012; 72:192–202.

Speroff L., Glass R. H., Kase N. G., eds. Menstrual Disorders in Gynecologic Endocrinology and Infertility, 6th Ed. Philadelphia, PA: Lippincott Williams & Wilkins, 1999; 557–574.

Speroff L. Alternative therapies for postmenopausal women. Intl. J. Fertil. Womens Med., 2005; 50 (3):101–104.

Spitz I. M., Chwalisz K. Progesterone receptor modulators and progesterone antagonists in women’s health. Steroids, 2000; 65:807–815.

Springhouse. Amenorrhea: professional guide to signs & symptoms. Ambler, PA: Lippincott Williams & Wilkins, 2006.

Stachenfeld N. S., Taylor H. S. Estrogen and progesterone effects on body fluid distribution. J. Appl. Physiol., 2004; 96:1011–1018.

Stahl S. M. Basic psychopharmacology of antidepressants, part 2: Estrogen as an adjunct to antidepressant treatment. J. Clin. Psychiatry, 1998; 59 Suppl 4:15–24.

Stahl S. M. Natural estrogen as an antidepressant for women. J. Clin. Psychiatry, 2001; 62:404–405.

Stanford J. B., Mikolajczyk R. T. Mechanisms of action of intrauterine devices: update and estimation of postfertilization effects. Am. J. Obstet. Gynecol., 2002; 187:1699–1708.

Staples L. D., et al. Migration of leukocytes into the uterus after acute removal of ovarian progesterone during early pregnancy in the sheep. Placenta, 1983; 4:339–350.

Stearns E. L., Winter J. S., Faiman C. Effects of coitus on gonadotropin, prolactin and sex steroid levels in man. J. Clin. Endocrinol. Metab., 1973; 37:687–691.

Stefanick M. L. Estrogens and progestins: background and history, trends in use, and guidelines and regimens approved by the US Food and Drug Administration. Am. J. Med., 2005; 118 (suppl 12B):64–73.

Stein D. G. The Case for Progesterone. Ann. NY. Acad. Sci., 2005; 1052:152–169.

Steiner M. Premenstrual syndrome and premenstrual dysphoric disorder: guidelines for management. J. Psychiatry Neurosci., 2000; 25 (5):459–68.

Stéphanie R., et al. Endometrial vessel maturation in women exposed to levonorgestrel releasing intrauterine system for a short or prolonged period of time. Hum. Reprod., 2007; 22 (12):3084–3091.

Stephenson M. D., Awartani K. A.,Robinson W. P. Cytogenetic analysis of miscarriages from couples with recurrent miscarriage: a case-control study. Hum. Reprod., 2002; 17:446–451.

Stephenson M. D. Management of recurrent early pregnancy loss. J. Reprod. Med., 2006; 51:303–310.

Stewart E. A., Nowak R. A. Leiomyoma-related bleeding: a classic hypothesis updated for the molecular era. Hum. Reprod. Update, 1996; 2:295–306.

Stewart E. A., Nowak R. A. New concepts in the treatment of uterine leiomyomas. Obstet. Gynecol., 1998; 92 (4 Pt 1):624–627.

Stewart J. A., Bulmer J. N., Murdoch A. P. Endometrial leucocytes: expression of steroid hormone receptors. J. Clin. Pathol., 1998; 51:121–126.

Stoll C., et al. Genetic and environmental factors in hypospadias. J. Med. Genet., 1990; 27:559–563.

Strauss J. The synthesis and metabolism of steroid hormones. In: Strauss J. F. III, Barbieri R. L., eds. Yen and Jaffe’s Reproductive Endocrinology 6th ed. Philadelphia, PA: Elsevier, 2009:4.

Strauss J. F. 3rd. Some new thoughts on the pathophysiology and genetics of polycystic ovary syndrome. Ann. NY. Acad. Sci., 2003; 997:42–48.

Strünker T., et al. The CatSper channel mediates progesterone-induced Ca2+ influx in human sperm. Nature, 2011; 471:382–386.

Studd J., Nappi R. E. Reproductive depression. Gynecol. Endocrinol., 2012; 28 (S (1)):42–45.

Studd J., Panay N. Hormones and depression in women. Climacteric, 2004; 7:338–346.

Studd J. A guide to hormone therapy for the treatment of depression in women. Climacteric, 2011; 14:637–642.

Studd J. Ovarian cycle syndrome. Gynecol. Endocrinol., 2009; 25:74.

Studd J. Spotlight on severe premenstrual syndrome and bipolar disorder: a frequent tragic confusion. Climacteric, 2011; 14:602.

Studd J. Why are estrogens rarely used for the treatment of depression in women? Gynecol. Endocrinol., 2007; 23:63–64.

Suarez S. S. Control of hyperactivation in sperm. Hum. Reprod. Update, 2008; 14:647–657.

Suchowsky G. K., Turolla E., Arcari G. Studies of the so-called virilizing effects of steroids in female rat fetuses. Endocrinology, 1967; 80:255–262.

Sun F., et al. Human sperm chemotaxis: Both the oocyte and its surrounding cumulus cells secrete sperm chemoattractants. Hum. Reprod., 2005; 20:761–767.

Sun F., et al. Lack of speciesspecificity in mammalian spem chemotaxis. Dev. Biol., 2003; 255:423–427.

Sundström-Poromaa I. Action of progesterone and progesterone metabolites in menstrual-cycle — related disorders. Headache, 2008; 48:S90-S98.

Sutton-Riley J. M., et al. A single serum test for measuring early pregnancy outcome with high predictive value. Clin. Biochem., 2006; 39:682–687.

Suzuki T., et al. Immunohistochemical distribution of progesterone, androgen and oestrogen receptors in the human ovary during the menstrual cycle: relationship to expression of steroidogenic enzymes. Hum. Reprod., 1994; 9:1589–1595.

Sweet R. A., et al. Study of the incidence of hypospadias in Rochester, Minnesota, 1940–1970, and a case-control comparison of possible etiologic factors. Mayo Clin. Proc., 1974; 49:52–58.

Swyer G., Daley D. Progesterone implantation in habitual abortion. BMJ, 1953; 1:1073–1086.

Syed V., Ho S. Progesterone-induced apoptosis in immortalized normal and malignant human ovarian surface epithelial cells involves enhanced FasL expression. Oncogene, 2003; 22 (44):6883–6890.

Szamatowicz J., et al. Fibromyomas and uterine contractions. Acta Obstet. Gynecol. Scand., 1997; 76:973–976.

Szekeres-Bartho J., et al. Progesterone as an immunomodulatory molecule. Int. J. Immunopharmacol., 2001; 1:1037–1048.

Szekeres-Bartho J., et al. Progesterone receptors in lymphocytes of liver-transplanted and transfused patients. Immunol. Lett., 1989; 22:259–261.

Szekeres-Bartho J., et al. Reactivity of lymphocytes to a progesterone-specific monoclonal antibody. Cell. Immunol., 1990; 125:273–283.

Szekeres-Bartho J., et al. The anti-abortive effect of PIBF in mice is manifested by modulating NK activity. Cell. Immunol., 1997; 177:194–199.

Szekeres-Bartho J., Faust Z., Varga P. The expression of a progesterone-induced immunomodulatory protein in pregnancy lymphocytes. Am. J/ Reprod. Immunol., 1995; 34:342–348.

Szekeres-Bartho J., Varga P., Petjsik B. ELISA test for detecting a progesterone-induced immunological factor in pregnancy serum. J. Reprod. Immunol., 1989; 16:19–29.

Szekeres-Bartho J. Immunological relationship between the mother and the fetus. Int. Rev. Immunol., 2002; 21:471–496.

Szlachter N., et al. Myometrial inhibiting activity of relaxin containing extracts of human corpora lutea of pregnancy. Am. J. Obstet. Gynecol., 1980; 136:584–586.

Tabibzadeh S., Babaknia A. The signals and molecular pathways involved in implantation, a symbiotic interaction between blastocyst and endometrium involving adhesion and tissue invasion. Human Reproduction, 1995; 10 (6):1579–1602.

Tabibzadeh S. The signals and molecular pathways involved in human menstruation, a unique process of tissue destruction and remodelling. Mol. Hum. Reprod., 1996; 2 (2):77–92.

Tahboub R., Arafah B. M. Sex steroids and the thyroid. Best Pract. Res. Clin. Endocrinol. Metab., 2009; 23:769–780.

Takacs P., et al. The effects of estrogen, progesterone and polypropylene mesh on vaginal smooth muscle cell proliferation. Muscle Res., 2010; 6 (1):9–15.

Takasugi N., Tomooka Y. Alteration of the critical period for induction of persistent oestrus by early postnatal treatment with gonadal steroids in neonatally cortisone-primed mice. J. Endocrinol., 1976; 69:293–294.

Tam A., et al. The role of female hormones on lung function in chronic lung diseases. BMC Women’s Health, 2011; 11:24.

Tantayaporn P., et al. The effect of estrogen and progesterone on the volume and electrolyte content of the uterine luminal fluid of the rat. Endocrinology, 1974; 95:1034–1045.

Tapanainen J., Penttinen J., Huhtaniemi I. Effect of progesterone treatment on the development and function of neonatal rat adrenals and testes. Biol. Neonate, 1979; 36:290–297.

Tarín J. J., Hamatani T., Cano A. A cute stress may induce ovulation in women. Reprod. Biol. Endocrinol., 2010; 8:53:1–13.

Tavaniotou A., Devroey P. Luteal hormonal profile of oocyte donors stimulated with a GnRH antagonist compared with natural cycles. Reprod. Biomed. Online, 2006; 13:326–330.

Tavaniotou A., et al. Comparison between different routes of progesterone administration as luteal phase support in infertility treatments. Hum. Reprod. Update, 2000; 6:139–148.

Taylor K. C., et al. Associations of Progesterone Receptor Polymorphisms with Age at Menarche and Menstrual Cycle Length. Horm. Res. Paediatr., 2010; 74:421–427

Taylor W. G., et al. Microdetermination of Diosgenin from Fenugreek (Trigonella foenum-graecum) Seeds. J. Agric. Food Chem., 2000; 48 (11):5206–5210.

Tempfer C. B., et al. A combination treatment of prednisone, aspirin, folate, and progesterone in women with idiopathic recurrent miscarriage: a matched-pair study. Fertil. Steril., 2006; 86:145–148.

Ter Host J. P. Relevance of Stress and Female Sex Hormones for Emotion and Cognition. Cell. Mol. Neurobiol., 2012; 32:725–735.

Tesarik J., Mendoza C. Defective function of a nongenomic progesterone receptor as a sole sperm anomaly in infertile patients. Fertil. Steril., 1992; 58:793–797.

Teves M. E., et al. Molecular mechanism for human sperm chemotaxis mediated by progesterone. PLoS One, 2009; 4:e8211.

Teves M. E., et al. Progesterone at the picomolar range is a chemoattractant for mammalian spermatozoa. Fertil. Steril., 2006; 86:745–749.

Thakur M. K., Paramanik V. Role of steroid hormone coregulators in health and disease. Hormone Research, 2009; 7:194–200.

The ovarian hormone. Lancet, 1926; 207:5340:26–27

The progesterone only pill. InnovAiT, 2011; 4 (9) 515–519.

Thibault C., Levasseur M. C. Ovulation. Human Reproduction, 1988; 3 (4):513–523.

Thomas P., Meizel S. Phosphatidylinositol 4,5-bisphosphate hydrolysis in human sperm stimulated with follicular fluid or progesterone is dependent upon Ca2+ influx. Biochem. J., 1989; 264:539–546.

Thomas S. L., Ellertson C. Nuisance or natural and healthy: should monthly menstruation be optional for women? Lancet, 2000; 355:922–924.

Thompson T. L., Moss R. L. Modulation of mesolimbic dopaminergic activity over the rat estrous cycle. Neurosci. Lett., 1997; 229:145–148.

Tibbetts T. A., et al. Progesterone receptors in the thymus are required for thymic involution during pregnancy and for normal fertility. Proc. Natl. Acad. Sci. USA, 1999; 96:12021–12026.

Tita A. T. N., Rouse D. J. Progesterone for preterm birth prevention: an evolving intervention. Am. J. Obstet. Gynecol., 2009; 200 (3):219–224.

Tomic V., et al. Oral micronized progesterone combined with vaginal progesterone gel for luteal support. Gynecol. Endocrinol., 2011; 27 (12):1010–1013.

Tone A. A., et al. Decreased progesterone receptor isoform expression in luteal phase fallopian tube epithelium and highgrade serous carcinoma. Endocr. Relat. Cancer, 2011; 18:221–234.

Tredway D. R., Warne D. W., Eshkol A., Alam V. Correlation between luteal serum progesterone levels and pregnancy in ovulation induction. Fertil. Steril., 2007; 1:88: S195.

Tsuji K., Sowa M., Nakano R. Relationship between human oocyte maturation and different follicular size. Biol. Reprod., 1985; 32:413–417.

Tuckey R. C., Bose H. S., Czerwionka I., Miller W. L. Molten globule structure and steroidogenic activity of N-218 MLN64 in human placental mitochondria. Endocrinology, 2004 Apr; 145 (4):1700–1707.

Tuckey R. C. Progesterone synthesis by the human placenta. Placenta, 2005; 26:273–281.

Tung L., et al. Antagonist occupied human progesterone B-receptors activate transcription without binding to progesterone response elements and are dominantly inhibited by A-receptors. Mol. Endocrinol., 1993; 7:1256–1265.

Unfer V., et al. Different routes of progesterone administration and polycystic ovary syndrome: A review of the literature. Gynecological. Endocrinology, August 2005; 21 (2):119–127.

Uribe A., Strauss J. F. 3rd, Martinez F. Contact sites from human placental mitochondria: characterization and role in progesterone synthesis. Arch. Biochem. Biophys., 2003; 413 (2):172–181.

Urman B., Tiras B., Yakin K. Assisted reproduction in the treatment of polycystic ovarian syndrome. Reprod. Biomed. Online, 2004; 8:419–430.

US Food and Drug Administration. Food and Drugs. US Code of Federal Regulations, Title 21, part 556.540, 1977; 364.

Vainio S., et al. Female development in mammals is regulated by Wnt-4 signalling. Nature, 1999; 397:405–409.

Vallet J. L., Christenson R. K. Effect of progesterone, mifepristone, and estrogen treatment during early pregnancy on conceptus development and uterine capacity in Swine. Biol. Reprod., 2004; 70:92–98.

Valley V. T., et al. Serum progesterone and endovaginal sonography by emergency physicians in the evaluation of ectopic pregnancy. Acad. Emerg. Med., 1998; 5:309–312.

Van den Berge M., et al. The role of female sex hormones in the development and severity of allergic and non-allergic asthma. Clin. Exp. Allergy, 2009; 39:1477–1481.

Van Keep P. A. The history and rationale of hormone replacement therapy. Muturitus, 1990; 12:163–170.

Van Kempen T. A., et al. Accelerated Ovarian Failure: A novel, chemically induced animal model of menopause. Brain Research, 2011; 379:176–187.

Van Vaerenbergh I., et al. Progesterone rise on hCG day in GnRH antagonist/rec-FSH stimulated cycles affects endometrial gene expression. RBM Online, 2011; 22:263–271.

Van Veen F. J., et al. The effects of female reproductive hormones in generalized social anxiety disorder. Intern. J. Psych. Med., 2009; 39:283–295.

Vasconcelos C., et al. Autoimmune progesterone urticaria. Gynecol. Endocrinol., 2000; 14:245–247.

Veitia R. A. FOXL2 versus SOX9: A lifelong «battle of the sexes». Bioessays, 2010; 32:375–380.

Velle W. The use of hormones in animal production. FAO Corporate Document Repository. http://www.fao.org/docrep/004/X6533E/X6533E01.htm

Venetis C. A., et al. Is progesterone elevation on the day of human chorionic gonadotrophin administration associated with the probability of pregnancy in in vitro fertilization? A systematic review and meta-analysis. Hum. Reprod. Update, 2007; 13:343–355.

Vercellini P., Cortesi I., Crosignani P. G. Progestins for symptomatic endometriosis: a critical analysis of the evidence. Fertil. Steril., 1997; 68:393–401.

Verhaegen J., et al. Accuracy of single progesterone test to predict early pregnancy outcome in women with pain or bleeding: meta-analysis of cohort studies. BMJ, 2012; 345:e6077.

Vetrivelan R., Mallick H. N., Kumar V. M. Tonic activity of alpha1 adrenergic receptors of the medial preoptic area contributes towards increased sleep in rats. Neuroscience, 2006; 139:1141–1151.

Vidal F., et al. FISH preimplantation diagnosis of chromosome aneuploidy in recurrent pregnancy wastage. J. Assist. Reprod. Genet., 1998; 15:310–313.

Vitzthum V. J., Spielvogel H.; Thornburg J. Interpopulational differences in progesterone levels during conception and implantation in humans. PNAS, 2004;101 (6):1443–1448.

Vlaanderen W., Treffers P. K. Prognosis of subsequent pregnancies after recurrent spontaneous abortion in first trimester. BMJ, 1987; 295:92–93.

Von Eye Corleta H., Capp., Cardoso Ferreira M. B. Pharmacokinetics of natural progesterone vaginal suppository. Gynecol. Obstet. Invest., 2004; 58:105–108.

Vuorento T., Huhtaniemi I. Daily levels of salivary progesterone during menstrual cycle in adolescent girls. Fertil. Steril., 1992; 58:685–690.

Vural P., Akgul C., Yildirim A., Canbaz M. Antioxidant defence in recurrent abortion. Clin. Chim. Acta. 2000; 295:169–177.

Wagner C. K., Kinsley C., Svare B. Mice: postpartum aggression is elevated following prenatal progesterone exposure. Horm. Behav., 1986; 20:212–221.

Wagner C. K., Nakayama A. Y., De Vries G. J. Potential role of maternal progesterone in the sexual differentiation of the brain. Endocrinol., 1998; 139:3658–3661.

Walch K., Hefler L., Nagele F. Oral dydrogesterone treatment during the first trimester of pregnancy: the Prevention of Miscarriage Study (PROMIS). A double-blind, prospectively randomized, placebo-controlled, parallel group trial. J. Matern. Fetal. Neonatal. Med., 2005; 18:265–269.

Walch K. T., Huber J. C. Progesterone for recurrent miscarriage: truth and deceptions. Best Practice & Research Clinical Obstetrics and Gynecology 2008; 22 (2):375–389.

Wallis C. J., Luttge W. G. Influence of estrogen and progesterone on glutamic acid decarboxylase activity in discrete regions of rat brain. J. Neurochem., 1980; 34:609–613.

Wallis M. C., et al. Sex determination in mammals — Before and after the evolution of SRY. Cel. Mol. Life Sci., 2008; 65:3182–3195.

Wambach G., Higgins I. Antimineralocorticoid action of progesterone in the rat: correlation of the effect on electrolyte excretion and interaction with renal mineralocorticoid receptors. Endocrinology, 1978; 102:1686–1693.

Wang H., et al. Progesterone receptor subtype B is differentially regulated in human endometrial stroma. Mol. Hum. Reprod., 1998; 4:407–412.

Ward K., Argyle V., Meade M., Nelson L. The heritability of preterm delivery. Obstet. Gynecol., 2005; 106 (6):1235–1239.

Watson N. R., et al. Treatment of severe premenstrual syndrome with oestradiol patches and cyclical oral norethisterone. Lancet, 1989; 2:730–732.

Wattanakumtornkul S., Pinto A. B., Williams D. B. Intranasal hormone replacement therapy. Menopause, 2003; 10:88–98.

Wegmann T. G., Lin H., Guilbert L., et al. Bidirectional cytokine interactions in maternal-fetal relationship: is successful pregnancy a Th2 phenomenon? Immunol. Today, 1993; 14:353–356.

Wegmann T. G. The cytokine basis for cross-talk between the maternal immune and reproductive systems. Curr. Opin. Immunol., 1990; 2:765–769.

Wei L. L., Miner R. Evidence for the existence of a third progesterone receptor protein in human breast cancer cell line T47D. Cancer Res., 1994; 54:340–343.

Weiser M. J., Foradori C. D., Handa R. J. Estrogen receptor beta in the brain: from form to function. Brain. Res. Rev., 2008; 57:309–320.

Wen E., et al. Estradiol, progesterone, testosterone profiles in human follicular fluid and cultured granulose cells from luteinized pre-ovulatory follicles. Reprod. Biol. Endocrinol., 2010; 8:117.

Westphal U., Stroupe S. D., Cheng S. L. Progesterone binding to serum proteins. Annals New York Academy of Sciences, 1977; 286:10–28.

Wetherington C. L. Sex differences and gonadal hormone influences in drug addiction and sexual behavior: Progress and possibilities. Hormones and Behavior, 2010; 58 (1):2–7.

Wharton L. R. Jr., Scott R. B. Experimental production of genital lesions with norethindrone. Am. J. Obstet. Gynecol., 1964; 89:701–715.

Whitcomb B. W., et al. Ovarian function and cigarette smoking in the BioCycle Study. Paediatr. Perinat. Epidemiol., 2010; 24 (5):433–440.

Whitehead M. I., et al. Absorption and metabolism of oral progesterone. BMJ, 1980; 280:825–827.

Whitney R., Burdick H. Effect of massive doses of an estrogen on ova transport in ovariectomized mice. Endocrinology, 1939; 24:45–49.

Wilcox A. J., Baird D. D., Weinberg C. R. Time of implantation of the conceptus and loss of pregnancy. N. Engl. J. Med., 1999; 340:1796–1799.

Wilcox A. J., et al. Incidence of early pregnancy loss. N. Engl. J. Med., 1988; 319:189–194.

Wilcox A. J., et al. Likelihood of conception with a single act of intercourse providing benchmark rates for assessment of post-coital contraceptives. Contraception, 2001; 63:211–215.

Wilcox A. J., Weinberg C. R., Baird D. D. Timing of sexual intercourse in relation to ovulation. Effects on the probability of conception, survival of the pregnancy, and sex of the baby. N. Engl. J. Med., 1995; 333:1517–1521.

Wilkens J., Critchley H. Progesterone receptor modulators in gynaecological practice. J. Fam. Plann. Reprod. Health Care, 2010; 36 (2):87–92.

Wilkins L., et al. Masculinization of the female fetus associated with administration of oral and intramuscular progestins during gestation: non-adrenal female pseudohermaphrodism. J. Clin. Endocrinol. Metab., 1958; 18:559–585.

Wilkins L. Masculinization of the female fetus due to the use of certain synthetic oral progestins during pregnancy. Arch. Anat. Microsc. Morphol. Exp., 1959; 48 (Suppl):313–329.

Williams N. I., et al. Effects of follicular phase exercise on luteinizing hormone pulse characteristics in sedentary eumenorrhoeic women. Clin. Endocrinol. (Oxf.), 1994; 41:787–794.

Williams S. C., Donahue J., Muasher S. J. Vaginal progesterone therapy during programmed cycles for frozen embryo transfer: an analysis of serum progesterone levels and pregnancy rates [abstract P-363]. Fertil. Steril., 2000; 74 (Suppl 1):S209.

Wilson K. M., et al. A prospective study of dietary acrylamide intake and the risk of breast, endometrial, and ovarian cancers. Cancer Epidemiol. Biomarkers Prev., 2010 October; 19 (10):2503–2515.

Wilson C. W., Loh H. S. Vitamin C and fertility. Lancet, 1973; 2:859–860.

Wilson M. A. GABA physiology: modulation by benzodiazepines and hormones. Crit. Rev. Neurobiol., 1996; 10:1–17.

Wingo C. S., Greenlee M. M. Progesterone: not just a sex hormone anymore? Kidney International 2011; 80:231–233.

Wise D. D., Felker A., Stahl S. M. Tailoring treatment of depression for women across the reproductive lifecycle: the importance of pregnancy, vasomotor symptoms, and other estrogen-related events in psychopharmacology. CNS Spectr, 2008; 13:647–662.

Wise P. M., et al. Estrogens: trophic and protective factors in the adult brain. Front Neuroendocrinol., 2001; 22:33–66.

Women’s Health. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA, 2002l; 288:321–333.

Woods K. S., Reyna R., Azziz R. Effect of oral micronized progesterone on androgen levels in women with polycystic ovary syndrome. Fertil. Steril., 2002; 77:1125–1127.

Woods M. N., et al. Hormone levels during dietary changes in premenopausal African-American women. J. Natl. Cancer Inst., 1996; 88:1369–1374.

World Health Organization. WHO Laboratory manual for the examination of human semen and semen-cervical mucus interaction. New York: Cambridge University Press, 1993.

Wu J. M., Zelinski M. B., Ingram D. K., Ottinger M. A. Models ovarian aging and menopause: current theories, hypotheses, and research. Experimental Biology and Medicine, 2005; 230:818–828.

Wu J. T., Dickmann, Johnson D. C. Effects of ovariectomy or hypophysectomy on day one of pregnancy on development and transport of fertilized rat eggs. J. Endocr., 1971; 49:507–513.

Wu Y., et al. Promoter hypermethylation of progesterone receptor isoform B (PR-B) in endometriosis. Epigenetics, 2006; 1:106–111.

Wyatt K. M., et al. The effectiveness of GnRHa with and without ’add-back’ therapy in treating premenstrual syndrome: a meta analysis. BJOG, 2004; 111:585–593.

Xia J., Reigada D., Mitchell C. H., Ren D. CatSper channel-mediated Ca2+ entry into mouse sperm triggers a tail-to-head propagation. Biol. Reprod., 2007; 77:551–559.

Xiao E., Ferin M. Stress-related disturbances of the menstrual cycle. Ann. Med., 1997; 29:215–219.

Yang S., Thiel K. W., Leslie K. K. Progesterone: the ultimate endometrial tumor suppressor. Trends Endocrinol. Metab., 2011b; 22 (4):145–152.

Ying C., et al. Progesterone receptor gene expression in preimplantation pig embryos. Eur. J. Endocrinol., 2000; 143:697–703.

Yip S. K., et al. Accuracy of clinical diagnostic methods of threatened abortion. Gynecol. Obstet. Invest., 2003; 56:38–42.

Yonkers K. A., Pearlstein T., Rosenheck R. A. Premenstrual disorders: bridging research and clinical reality. Arch. Womens Ment. Health, 2003; 6 (4):287–292.

Yoshida T. Infertility update: use of assisted reproductive technology. J. Am. Pharm. Assoc., 1999; 39:65–72.

Younis J. S., et al. A simple multivariate score could predict ovarian reserve, as well as pregnancy rate, in infertile women. Fertil. Steril., 2010; 94 (2):655–661.

Yovel I., et al. High progesterone levels adversely affect embryo quality and pregnancy rates in in vitro fertilization and oocyte donation programs. Fertil. Steril., 1995; 64:128–131.

Yui J., et al. Cytotoxicity of tumor necrosis factor-alpha and gammainterferon against primary human placental trophoblast. Placenta, 1994; 15:819–835.

Zachariades E., et al. Changes in placental progesterone receptors in term and preterm labour. Placenta, 2012; 33:367–372.

Zalanyi S. Progesterone and ovulation. European Journal of Obstetrics, Gynecology and Reproductive Biology, 2001; 98 (2):152–159.

Zarrow M. X., Campbell P. S., Clark J. H. Pregnancy following coital-induced ovulation in a spontaneous ovulator. Science, 1968; 159:329–330.

Zhang J., et al. Progesterone inhibits activation of latent matrix metalloproteinase (MMP) -2 by membrane-type 1 MMP: enzymes coordinately expressed in human endometrium. Biol. Reprod., 2000; 62:85–94.

Zhang J., Salamonsen L. A. In vivo evidence for active matrix metalloproteinases in human endometrium supports their role in tissue breakdown at menstruation. J. Clin. Endocrinol. Metab., 2002; 87:2346–2351.

Zhang K., et al. Onset of ovulation after menarche in girls: a longitudinal study. J. Clin. Endocrinol. Metab., 2008; 93:1186–1194.

Zhanga Y., et al. Progesterone metabolism in adipose cells. Mol. Cel. Endocrinol., 2009; 298:76–83.

Zheng T., et al. How to determine the dosage of oral progesterone among patients with menstrual disorders? Chin. Med. J., 2012; 125 (11):1970–1974.

Zhou Y., et al.Cigarette Smoke Increases Progesterone Receptor and Homeobox A10 Expression in Human Endometrium and Endometrial Cells: A Potential Role in the Decreased Prevalence of Endometrial Pathology in Smokers. Biol. Reprod., 2011; 84:1242–1247.

Zhou B., et al. Cigarette smoking and the risk of endometrial cancer: a meta-analysis. Am. J. Med., 2008; 121:501–508.

Zhu Y., Bond J., Thomas P. Identification, classification, and partial characterization of genes in humans and other vertebrates homologous to a fish membrane progestin receptor. Proc. Natl. Acad/ Sci. USA, 2003a; 100:2237–2242.

Zhu Y., et al. Cloning, expression, and characterization of a membrane progestin receptor and evidence it is an intermediary in meiotic maturation of fish oocytes. Proc. Natl. Acad. Sci. USA, 2003b; 100:2231–2236.

Zirkin B. R. Where Do Adult Leydig Cells Come From? Biol. Reprod., 2010; 82:1019–1020.

Zlotnik A., et al. The Effects of Estrogen and Progesterone on Blood Glutamate Levels: Evidence from Changes of Blood Glutamate Levels During the Menstrual Cycle in Women. Biol. Reprod., 2011; 84:581–586.

Zumoff B., et al. The effect of smoking on serum progesterone, estradiol, and luteinizing hormone levels over a menstrual cycle in normal women. Steroids, 1990; 55:507–511.

Апресян С. В., Дурандин Ю. М., Семятов С. Д. Эволюция КОК: от дефицита к проблеме выбора. Status Praesens, 2011; 80–84.

Майоров М. В. Pro et contra. Прогестины и антипрогестины. Провизор, 2007; 11:19–21.

Майоров М. В., Жученко С. И., Черняк О. Л. Лейомиома матки: что нового? Новации тактики и терапии, часть 1. Провизор, 2012; 5:6–9.

Майоров М. В., Жученко С. И., Черняк О. Л., Голубова М. А. Эндометриоз: что нового? Новации тактики и терапии. Новости медицины и фармации, 2012; 3 (401);18–22.

Майоров М. В., Жученко С. И., Черняк О. Л., Голубова М. А. Эндометриоз: что нового? Новации тактики и терапии. Современная фармация, 2011; 10:52–62.

Майоров М. В., Жученко С. И. Современная гормональная контрацепция: опасности мнимые и реальные. Провизор, 2010; 24:28–32.

Майоров М. В., Жученко С. И. Гестагенная контрацепция: показания, преимущества, особенности. Провизор, 2011; 42–47.

Майоров М. В. DACH-syndrome, PMDD, ПМС (предменструальный синдром): проблемы патогенеза, особенности терапии. Провизор, 2007; 21:33–36.

Майоров М. В. Аутоиммунный оофорит. Актуальные особенности патогенеза, диагностики и лечения. Репродуктивное здоровье женщины, 2006; 4 (29):59–61.

Майоров М. В. Гестагены в акушерско-гинекологической практике. Провизор, 2004; 7:26–29.

Майоров М. В. Заместительная гормональная терапия: панацея или очередная дань моде? Провизор, 2003; 20:42–46.

Майоров М. В. Неконтрацептивные свойства оральных контрацептивов. Провизор, 2003; 11:16–18.

Майоров М. В. Некоторые аспекты заместительной гормональной терапии. Вісник фармакології та фармації, 2004.

Майоров М. В. Синдром непереносимости гестагенов: причины и следствия. Что предпринять? Провизор, 2004; 16:31–33.

Майоров М. В. Эстрогены — старые приятели и новые знакомые. Провизор, 2005; 5:27–30.